<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Genet</journal-id>
<journal-id journal-id-type="publisher-id">Front. Genet.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Genetics</journal-title>
</journal-title-group>
<issn pub-type="epub">1664-8021</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32719717</article-id>
<article-id pub-id-type="pmc">7348066</article-id>
<article-id pub-id-type="doi">10.3389/fgene.2020.00646</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Genetics</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Genetic Etiology Shared by Multiple Sclerosis and Ischemic Stroke</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Tian</surname>
<given-names>Zhu</given-names>
</name>
<uri xlink:href="http://loop.frontiersin.org/people/813910/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Song</surname>
<given-names>Yang</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yao</surname>
<given-names>Yang</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Guo</surname>
<given-names>Jie</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gong</surname>
<given-names>Zhongying</given-names>
</name>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/445219/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Zhiyun</given-names>
</name>
<xref ref-type="corresp" rid="c002">
<sup>*</sup>
</xref>
</contrib>
</contrib-group>
<aff><institution>Department of Neurology, Tianjin First Central Hospital</institution>, <addr-line>Tianjin</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Qinghua Jiang, Harbin Institute of Technology, China</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Hui Shen, Tianjin Medical University, China; Limin Wu, Massachusetts General Hospital and Harvard Medical School, United States</p>
</fn>
<corresp id="c001">*Correspondence: Zhongying Gong, <email>13212121250@163.com</email></corresp>
<corresp id="c002">Zhiyun Wang, <email>13820585625@163.com</email></corresp>
<fn fn-type="other" id="fn004">
<p>This article was submitted to Statistical Genetics and Methodology, a section of the journal Frontiers in Genetics</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>03</day>
<month>7</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<year>2020</year>
</pub-date>
<volume>11</volume>
<elocation-id>646</elocation-id>
<history>
<date date-type="received">
<day>24</day>
<month>10</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>27</day>
<month>5</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2020 Tian, Song, Yao, Guo, Gong and Wang.</copyright-statement>
<copyright-year>2020</copyright-year>
<copyright-holder>Tian, Song, Yao, Guo, Gong and Wang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Although dramatic progress has been achieved in the understanding and treatment of multiple sclerosis (MS) and ischemic stroke (IS), more precise and instructive support is required for further research. Recent large-scale genome-wide association studies (GWASs) have already revealed risk variants for IS and MS, but the common genetic etiology between MS and IS remains an unresolved issue. This research was designed to overlapping genes between MS and IS and unmask their transcriptional features. We designed a three-section analysis process. Firstly, we computed gene-based analyses of MS GWAS and IS GWAS data sets by VGEAS2. Secondly, overlapping genes of significance were identified in a meta-analysis using the Fisher’s procedure. Finally, we performed gene expression analyses to confirm transcriptional changes. We identified 24 shared genes with Bonferroni correction (<italic>P</italic><sub>combined</sub> &lt; 2.31E-04), and five (<italic>FOXP1</italic>, <italic>CAMK2G</italic>, <italic>CLEC2D</italic>, <italic>LBH</italic>, and <italic>SLC2A4RG</italic>) had significant expression differences in MS and IS gene expression omnibus data sets. These meaningful shared genes between IS and MS shed light on the underlying genetic etiologies shared by the diseases. Our results provide a basis for in-depth genomic studies of associations between MS and IS.</p>
</abstract>
<kwd-group>
<kwd>multiple sclerosis</kwd>
<kwd>ischemic stroke</kwd>
<kwd>genome-wide association studies</kwd>
<kwd>gene-based test</kwd>
<kwd>gene expression analyses</kwd>
</kwd-group>
<counts>
<fig-count count="0"></fig-count>
<table-count count="3"></table-count>
<equation-count count="1"></equation-count>
<ref-count count="86"></ref-count>
<page-count count="9"></page-count>
<word-count count="0"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="S1">
<title>Introduction</title>
<p>Multiple sclerosis and IS are two major neurological diseases with serious sequelae such as motor and/or sensory disabilities, cognitive impairment, and mental disorders (<xref ref-type="bibr" rid="B18">Compston and Coles, 2008</xref>; <xref ref-type="bibr" rid="B39">Johnson et al., 2016</xref>). Researchers are increasingly interested in the genetics of complex human diseases associated with high personal, family, and social burden, including MS and IS. Clarifying the genetics of these conditions can create a “strategic hub” for further studies to prioritize targeted treatments.</p>
<p>Multiple sclerosis is a chronic autoimmune disease in the CNS mainly characterized by demyelination in brain and spinal cord (<xref ref-type="bibr" rid="B18">Compston and Coles, 2008</xref>). The etiology of MS is heterogeneous, and both the environment and genetics are influential components (<xref ref-type="bibr" rid="B19">Dendrou et al., 2015</xref>). As environmental variants are complicated, the genetic variants are regarded as a possible direction to make progress in immune-related mechanisms and therapies (<xref ref-type="bibr" rid="B7">Belbasis et al., 2015</xref>; <xref ref-type="bibr" rid="B19">Dendrou et al., 2015</xref>). Numerous large-scale GWASs revealed more than 200 susceptible loci of MS, such as <italic>HLA</italic>, forkhead box protein P1 (<italic>FOXP1</italic>), <italic>IQCB1</italic>, <italic>SLC9A9</italic>, and <italic>CD226</italic> (<xref ref-type="bibr" rid="B46">Liu et al., 2017a</xref>; <xref ref-type="bibr" rid="B34">International Multiple Sclerosis Genetics Consortium, 2019</xref>). The pathway-based analysis results of MS risk variants were mostly enriched in immune- and/or inflammation-related processes (<xref ref-type="bibr" rid="B33">International Multiple Sclerosis Genetics Consortium, 2013</xref>; <xref ref-type="bibr" rid="B47">Liu et al., 2017b</xref>, <xref ref-type="bibr" rid="B48">c</xref>). Decades of progress in genetics have shed light on MS mechanisms and therapies. Several US Food and Drug Administration (FDA)-approved drugs have been used in patients with MS, such as ocrelizumab, daclizumab, and mitoxantrone (<xref ref-type="bibr" rid="B4">Baecher-Allan et al., 2018</xref>).</p>
<p>Ischemic stroke accounts for 70% to 85% of stroke cases, which is the most common cause of death and long-term disability worldwide (<xref ref-type="bibr" rid="B41">Khan et al., 2013</xref>; <xref ref-type="bibr" rid="B39">Johnson et al., 2016</xref>). Many pharmacologic therapies have been used to reduce damage and improve the prognosis of IS in preclinical and clinical trials, including thrombolytic, antithrombotic, antioxidation, and neuroprotective agents (<xref ref-type="bibr" rid="B28">Gladstone et al., 2002</xref>; <xref ref-type="bibr" rid="B83">Yu et al., 2005</xref>; <xref ref-type="bibr" rid="B12">Chamorro et al., 2016</xref>; <xref ref-type="bibr" rid="B78">Wechsler et al., 2018</xref>). To date, intravenous alteplase is the primary FDA-approved drug for IS. However, thrombolysis benefits a limited number of patients with IS because of the limited “therapeutic time window” and the unpredictable outcomes of recanalization. More attention should be paid to develop adjuvant treatments for IS that target inflammation and oxidative stress (<xref ref-type="bibr" rid="B12">Chamorro et al., 2016</xref>). Recent GWASs have uncovered ∼35 genetic risk regions for IS and hemorrhagic stroke (<xref ref-type="bibr" rid="B21">Dichgans et al., 2019</xref>). Early GWASs of IS identified and replicated the significant relationship for IS at <italic>ABO</italic>, cardioembolic stroke near <italic>PITX2</italic> and <italic>ZFHX3</italic>, and for large-vessel stroke at <italic>HDAC9</italic> and the 9p21 locus (<xref ref-type="bibr" rid="B8">Bellenguez et al., 2012</xref>; <xref ref-type="bibr" rid="B75">Traylor et al., 2012</xref>; <xref ref-type="bibr" rid="B52">Malik et al., 2016</xref>). <xref ref-type="bibr" rid="B51">Malik et al. (2018)</xref> implemented a comprehensive multiancestry GWAS using ancestral meta-analyses of 67,162 IS cases and 454,450 healthy controls. Twenty-two new loci were discovered and used for further pathway and drug–target analyses (<xref ref-type="bibr" rid="B51">Malik et al., 2018</xref>). <xref ref-type="bibr" rid="B74">Torres-Aguila et al. (2019)</xref> found that 14q24.3 locus was associated with leukocyte counts during the first 24 h after IS. Genetic and related functional studies are considered one of the breakthrough points for IS therapy (<xref ref-type="bibr" rid="B21">Dichgans et al., 2019</xref>). So far, because of the limitation of known GWAS data, the common gene variant that had been proved both MS and IS risk gene was <italic>SLC44A2</italic> (<italic>P-</italic><sub><italic>MS</italic></sub> = 3.5E-09, <italic>P-</italic><sub><italic>IS</italic></sub> = 4.72E-08) (<xref ref-type="bibr" rid="B35">International Multiple Sclerosis Genetics Consortium et al., 2013</xref>; <xref ref-type="bibr" rid="B51">Malik et al., 2018</xref>).</p>
<p>Clinical studies revealed an increased prevalence of IS in MS patients compared with controls (<xref ref-type="bibr" rid="B53">Marrie et al., 2015</xref>; <xref ref-type="bibr" rid="B30">Hong et al., 2019</xref>). <xref ref-type="bibr" rid="B76">Tseng et al. (2015)</xref> enrolled 1,174 Chinese MS patients and 4,696 matched healthy Chinese controls. After following up for 5 years, they found that the MS group got a higher risk of stroke [hazard ratio (HR) = 12.1 for the first year; HR = 4.69 for the rest years] than the control cohort. As more immunological characteristics of human complex diseases such as MS have been uncovered, the neuroinflammatory mechanisms of IS should have deeper exploration (<xref ref-type="bibr" rid="B25">Fu et al., 2015</xref>). For example, the natural killer (NK) cells aggravated the infarct area after IS, but their influence on MS was proven to be dependent on the course of disease (<xref ref-type="bibr" rid="B14">Chanvillard et al., 2013</xref>; <xref ref-type="bibr" rid="B26">Gan et al., 2014</xref>). Based on preclinical studies, more immunomodulatory drugs have been administered in IS clinical translation experiments including natalizumab (<xref ref-type="bibr" rid="B24">Elkins et al., 2017</xref>) and fingolimod (<xref ref-type="bibr" rid="B86">Zhu et al., 2015</xref>; <xref ref-type="bibr" rid="B72">Tian et al., 2018</xref>), which are the FDA-approved agents for MS.</p>
<p>Here, we focus on the commonality genetic etiologies between MS and IS. First, we conducted gene-based testing of MS and IS GWAS data sets. Next, a meta-analysis was conducted to sort the shared significant genes out. Finally, we implemented differential expression analyses for shared significant genes via four gene expression omnibus (GEO) data sets.</p>
</sec>
<sec id="S2" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="S2.SS1">
<title>GWAS Data Set</title>
<p>The large-scale MS GWAS data set consisted of 9,772 MS cases from the IMSGC and 17,376 controls from the WTCCC2. And cases were gathered by 23 teams operating in 15 countries. All individuals were self-reported as being of European descent. The original research conducted sample and single-nucleotide polymorphism (SNP) QC to create SNP metric strainers. In sample QC, Bayesian clustering and principal components analysis were mainly used to identify qualified samples. Researchers developed and utilized two novel methods (automated cluster checking and beta-binomial model) in SNP QC to exclude SNPs identified because of incorrect genotype calling. Finally, 464,357 autosomal SNPs from the entire data set were obtained for further analysis (<xref ref-type="bibr" rid="B36">International Multiple Sclerosis Genetics Consortium et al., 2011</xref>).</p>
<p>The IS data set was summarized from the METASTROKE collaboration’s discovery stage. In this stage, genotyped data from 12 case–control GWASs correspond to 10,307 IS cases and 19,326 controls (ASGC: 1,162 IS cases and 1,244 controls; BRAINS: 371 IS cases and 2,640 controls; GASROS_affy: 485 IS cases and 3,030 controls; GASROS_illumina: 296 IS cases and 377 controls; GEOS: 448 IS cases and 498 controls; HPS: 588 IS cases and 571 controls; ISGS-SWISS: 1,014 IS cases and 1,370 controls; MILANO: 366 IS cases and 407 controls; VISP: 1,723 IS cases and 1,047 controls; WHI: 306 IS cases and 2,170 controls; WTCCC2-D: 1,174 IS cases and 797 controls; WTCCC2-UK: 2,374 IS cases and 5,175 controls; all individuals in the discovery stage were Caucasian). After QC by logistic regression analysis and meta-analysis, 9,541,572 SNPs were available for gene-based testing (<xref ref-type="bibr" rid="B52">Malik et al., 2016</xref>).</p>
</sec>
<sec id="S2.SS2">
<title>Gene-Based Test of MS and IS GWAS Using VEGAS</title>
<p>We utilized the VEGAS2 to execute more elastic gene-based testing for MS and IS GWAS. The chief distinguishing feature of VEGAS2 is that this approach is computationally feasible and can be applied to any GWAS experimental design by using the summary GWAS data (<xref ref-type="bibr" rid="B57">Mishra and Macgregor, 2015</xref>). After uploading the SNP information (rs-number and <italic>P</italic> value of both GWASs) to VEGAS2, we selected 1000G EUROPEAN as the population reference group. For considering both the physical position and LD profiles of SNPs with others in gene-based testing, we chose “0kbldbin outside gene and SNPs in LD <italic>r</italic><sup>2</sup> &gt; 0.8” (<xref ref-type="bibr" rid="B16">Christoforou et al., 2012</xref>). For each gene definition, <italic>P</italic> values of SNPs were first changed to upper tail χ<sup>2</sup> statistics with one degree of freedom (<italic>df</italic>) in the gene definition. And then, if SNPs are in linkage equilibrium, the statistics of gene-based tests would have a χ<sup>2</sup> distribution with <italic>n df</italic> under the null hypothesis. We used the reference population group of 1000 Genomes European and the model of Σ (<italic>n</italic> × <italic>n</italic> matrix of LD [<italic>r</italic>] values) for SNP correlation, because LD for the n SNPs occurs frequently. Significance was tested with reference to the aggregate χ<sup>2</sup> statistics for each gene to simulated repetition from a multivariate normal distribution in which mean = 0 and variance = Σ. The empirical <italic>P</italic> value of every gene was calculated via the formula, <italic>P</italic> = <italic>r</italic> + 1/m + 1, where <italic>r</italic> was the number of cases where the simulation statistics surpassed the observed statistics, and <italic>m</italic> was the number of simulations (<xref ref-type="bibr" rid="B57">Mishra and Macgregor, 2015</xref>). In this gene-based testing, we screened the shared genes with nominal significance respectively (<italic>P-</italic><sub><italic>MS</italic></sub> &lt; 0.05, <italic>P-</italic><sub><italic>IS</italic></sub> &lt; 0.05).</p>
</sec>
<sec id="S2.SS3">
<title>Meta-Analysis of MS and IS GWAS</title>
<p>To combine <italic>P</italic> values calculated by VEGAS2 for MS and IS GWAS, we used Fisher’s method to perform meta-analysis for every overlapped gene. For a given gene, the formula for the statistic is as follows:</p>
<disp-formula id="S2.Ex1">
<mml:math id="M1">
<mml:mrow>
<mml:msup>
<mml:mtext>x</mml:mtext>
<mml:mn>2</mml:mn>
</mml:msup>
<mml:mo>=</mml:mo>
<mml:mrow>
<mml:mo>-</mml:mo>
<mml:mrow>
<mml:mn>2</mml:mn>
<mml:mo>⁢</mml:mo>
<mml:mrow>
<mml:munderover>
<mml:mo movablelimits="false">∑</mml:mo>
<mml:mrow>
<mml:mi>i</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
<mml:mi>k</mml:mi>
</mml:munderover>
<mml:mrow>
<mml:mi>ln</mml:mi>
<mml:mo>⁡</mml:mo>
<mml:mrow>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mi>P</mml:mi>
<mml:mi>i</mml:mi>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:mrow>
</mml:mrow>
</mml:mrow>
</mml:mrow>
</mml:math>
</disp-formula>
<p>For the <italic>i</italic><sub><italic>th</italic></sub> study, <italic>P</italic><sub><italic>i</italic></sub> is the <italic>P</italic> value of the genes, and <italic>k</italic> is the entire count of studies. <italic>x</italic><sup>2</sup> abides by a <italic>c</italic><sup>2</sup> distribution with 2k degrees of freedom (<xref ref-type="bibr" rid="B6">Begum et al., 2012</xref>). The gene-based meta-analysis was performed with R software.<sup><xref ref-type="fn" rid="footnote1">1</xref></sup></p>
<p>Following the meta-analysis, we performed Bonferroni correction to control type I error. The combined <italic>P</italic> value was less than 0.05/2<italic>n</italic>, where <italic>n</italic> was the number of shared genes with previous nominal <italic>P</italic> value (<italic>P</italic> &lt; 0.05).</p>
</sec>
<sec id="S2.SS4">
<title>MS and IS Case–Control Gene Expression Analysis</title>
<p>We further investigated the differential expression of shared genes in the MS and IS patients and healthy control subjects using gene expression data sets from the NCBI GEO database.<sup><xref ref-type="fn" rid="footnote2">2</xref></sup></p>
<p>Immune cells from whole blood are the typical samples for gene expression analysis in patients with MS. PBMCs from 12 MS female patients under Poser’s criteria and 15 unrelated female controls were isolated from whole blood. The extracted samples were tested on the Affymetrix Gene Chip Human Genome U133 Plus 2.0 Array (<xref ref-type="bibr" rid="B40">Kemppinen et al., 2011</xref>). The expression data were obtained from GEO series GSE21942. In GEO series GSE43591, samples were extracted from 10 relapsing–remitting MS patients diagnosed in accordance with the criteria of <xref ref-type="bibr" rid="B54">McDonald et al. (2001)</xref> and 10 age- and sex-matched controls. T cells were purified through CD14<sup>+</sup> removal sorting and CD3<sup>+</sup>-positive selection from PBMCs. Transcriptional data were examined with Human Genome HG-U133 plus 2.0 arrays (<xref ref-type="bibr" rid="B38">Jernas et al., 2013</xref>).</p>
<p>Ischemic stroke case–control expression analyses were performed to identify differentially expressed genes in the GEO series. GEO series GSE16561 provided the raw mRNA expression data from peripheral whole blood of a study of 39 IS patients and 24 healthy controls (<xref ref-type="bibr" rid="B59">O’Connell et al., 2017</xref>). More information about the inclusion and exclusion criteria was provided in the original study (<xref ref-type="bibr" rid="B59">O’Connell et al., 2017</xref>). RNA data from the blood of 23 control samples and 69 cardioembolic stroke samples were analyzed in GEO series GSE58294. Cardioembolic stroke is a subtype of IS and has unique genetic traits (<xref ref-type="bibr" rid="B68">Stamova et al., 2014</xref>). In the original research, 69 cardioembolic stroke samples were collected from 23 patients at three time points to monitor transcriptional changes in the first 24 h. Twenty-three subjects without symptomatic vascular disease history were recruited as VRFCs (<xref ref-type="bibr" rid="B68">Stamova et al., 2014</xref>). And we used all the 69 cardioembolic stroke samples as a whole (including the samples of three time points) to compare with the samples from VRFCs.</p>
<p>To calculate differential expression between case–control samples, we utilized GEO2R and performed GEO query and limma R packages (<xref ref-type="bibr" rid="B5">Barrett et al., 2013</xref>). Among four differential expression data sets, those with the smallest <italic>P</italic> value for each shared gene in MS and IS were selected for further analysis.</p>
</sec>
</sec>
<sec id="S3">
<title>Results</title>
<sec id="S3.SS1">
<title>Gene-Based Test for MS and IS With VEGAS2</title>
<p>We uploaded the 464,357 MS and 9,541,572 IS SNP rs IDs and associated <italic>P</italic> values for gene-based analysis. We sorted 1,353 genes with <italic>P</italic>-<sub><italic>MS</italic></sub> &lt; 0.05 from a total of 14,811 MS gene sets obtained by VEGAS2. After Bonferroni correction (<italic>P</italic> &lt; 0.05/14,811 = 3.38E-06), 47 non-major histocompatibility complex (MHC) and MHC risk variants were sorted including known risk genes such as <italic>AHI1</italic>, <italic>RGS1</italic>, <italic>SP140</italic>, <italic>IQCB</italic>, <italic>IL2RA</italic>, <italic>TNFRSF1A</italic>, <italic>CLEC16A</italic>, <italic>GALC</italic>, <italic>TNFSF14</italic>, and <italic>CYP24A1</italic>. The good applicability of VEGAS2 for gene-based test was proven by the well-replicated genes above. Information of the gene-wide significant genes of MS is shown in <xref ref-type="supplementary-material" rid="TS1">Supplementary Table S1</xref>. In IS data sets, 1,290 genes with <italic>P</italic>-<sub><italic>IS</italic></sub> &lt; 0.05 were screened out from 21,913 IS genes via VEGAS2. However, no IS variant achieved the strict threshold (<italic>P-</italic><sub><italic>IS</italic></sub> &lt; 0.05/21,913 = 2.28E-06). And we utilized a looser significance threshold (<italic>P</italic> &lt; 1.00E-04) and identified two genes that satisfied this threshold set: <italic>ZYX</italic> (<italic>P</italic> &lt; 2.60E-05) and <italic>NCR3LG1</italic> (<italic>P</italic> &lt; 8.10E-05).</p>
<p>After making an intersection between 1,353 MS genes and 1,290 IS genes (<italic>P</italic>-<sub><italic>MS</italic></sub> &lt; 0.05, <italic>P-</italic><sub><italic>IS</italic></sub> &lt; 0.05), we obtained 108 nominal shared genes. We performed meta-analysis for the 108 shared genes and obtained the <italic>P</italic><sub>–combined</sub> for each gene. And then 24 overlapped significant genes were identified with <italic>P</italic><sub>–combined</sub> &lt; 2.31E-04 (0.05/2<sup>∗</sup>108), including <italic>LBH</italic> at 2p23.1, <italic>STAT4</italic> at 2q32.2-q32.3, <italic>FOXP1</italic> at 3p13, <italic>TEC</italic> at 4p12-p11, <italic>MICB</italic>/<italic>NFKBIL1</italic> at 6p21.33, <italic>IL6</italic> at 7p15.3, <italic>CAMK2G</italic> at 10q22.2, <italic>B4GALNT1</italic> at 12q13.3, <italic>BRAP</italic> at 12q24.12, <italic>CLEC2D</italic>/<italic>CLECL1</italic> at 12p13.31, <italic>HECTD4</italic>/<italic>NAA25</italic> at 12q24.13, <italic>OS9</italic> at 12q13.3-q14.1, <italic>NUDT14</italic> at 14q32.33, <italic>PDE4C</italic> at 19p13.11, <italic>SLC44A2</italic> at 19p13.2, and <italic>LIME1</italic>/<italic>RTEL1</italic>/<italic>RTEL1-TNFRSF6B</italic>/<italic>SLC2A4RG</italic>/<italic>ZBTB46</italic>/<italic>ZGPAT</italic> at 20q13.33. The detailed results are listed in <xref ref-type="table" rid="T1">Table 1</xref>.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>The overlapped significant gene sets screened by VEGAS of multiple sclerosis (MS) and ischemic stroke (IS).</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="4" rowspan="1" valign="top">MS<hr/></td>
<td align="center" colspan="4" rowspan="1" valign="top">IS<hr/></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Chr</td>
<td align="center" colspan="1" rowspan="1" valign="top">Gene</td>
<td align="center" colspan="1" rowspan="1" valign="top"><italic>P</italic> value</td>
<td align="center" colspan="1" rowspan="1" valign="top">nSNPs</td>
<td align="center" colspan="1" rowspan="1" valign="top">Top-SNP</td>
<td align="center" colspan="1" rowspan="1" valign="top">Top-SNP <italic>P</italic> value</td>
<td align="center" colspan="1" rowspan="1" valign="top"><italic>P</italic> value</td>
<td align="center" colspan="1" rowspan="1" valign="top">nSNPs</td>
<td align="center" colspan="1" rowspan="1" valign="top">Top-SNP</td>
<td align="center" colspan="1" rowspan="1" valign="top">Top-SNP <italic>P</italic> value</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>P</italic>
<sub>combined</sub>
</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">2</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>LBH</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">8.34E-04</td>
<td align="center" colspan="1" rowspan="1" valign="top">8</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs17321999</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.41E-04</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.39E-03</td>
<td align="center" colspan="1" rowspan="1" valign="top">105</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs79251390</td>
<td align="center" colspan="1" rowspan="1" valign="top">2.45E-04</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.70E-05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">2</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>STAT4</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.00E-04</td>
<td align="center" colspan="1" rowspan="1" valign="top">20</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs6752770</td>
<td align="center" colspan="1" rowspan="1" valign="top">2.48E-04</td>
<td align="center" colspan="1" rowspan="1" valign="top">4.17E-02</td>
<td align="center" colspan="1" rowspan="1" valign="top">239</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs35672585</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.25E-03</td>
<td align="center" colspan="1" rowspan="1" valign="top">5.58E-05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">3</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>FOXP1</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">3.53E-04</td>
<td align="center" colspan="1" rowspan="1" valign="top">137</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs1499895</td>
<td align="center" colspan="1" rowspan="1" valign="top">4.51E-05</td>
<td align="center" colspan="1" rowspan="1" valign="top">3.80E-02</td>
<td align="center" colspan="1" rowspan="1" valign="top">700</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs7616330</td>
<td align="center" colspan="1" rowspan="1" valign="top">9.97E-05</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.64E-04</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">4</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>TEC</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">4.85E-04</td>
<td align="center" colspan="1" rowspan="1" valign="top">37</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs17471024</td>
<td align="center" colspan="1" rowspan="1" valign="top">6.21E-05</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.11E-02</td>
<td align="center" colspan="1" rowspan="1" valign="top">494</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs73817607</td>
<td align="center" colspan="1" rowspan="1" valign="top">2.69E-04</td>
<td align="center" colspan="1" rowspan="1" valign="top">7.07E-05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">6</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>MICB</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.00E-06</td>
<td align="center" colspan="1" rowspan="1" valign="top">4</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs2844498</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.58E-54</td>
<td align="center" colspan="1" rowspan="1" valign="top">4.27E-03</td>
<td align="center" colspan="1" rowspan="1" valign="top">213</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs2844498</td>
<td align="center" colspan="1" rowspan="1" valign="top">7.51E-04</td>
<td align="center" colspan="1" rowspan="1" valign="top">8.66E-08</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">6</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>NFKBIL1</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.00E-06</td>
<td align="center" colspan="1" rowspan="1" valign="top">3</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs6929796</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.05E-32</td>
<td align="center" colspan="1" rowspan="1" valign="top">2.39E-02</td>
<td align="center" colspan="1" rowspan="1" valign="top">68</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs114205738</td>
<td align="center" colspan="1" rowspan="1" valign="top">6.99E-04</td>
<td align="center" colspan="1" rowspan="1" valign="top">4.43E-07</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">7</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>IL6</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">3.60E-05</td>
<td align="center" colspan="1" rowspan="1" valign="top">2</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs2066992</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.89E-05</td>
<td align="center" colspan="1" rowspan="1" valign="top">3.58E-02</td>
<td align="center" colspan="1" rowspan="1" valign="top">20</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs2069832</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.32E-02</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.88E-05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">10</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>CAMK2G</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">4.52E-04</td>
<td align="center" colspan="1" rowspan="1" valign="top">5</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs2675671</td>
<td align="center" colspan="1" rowspan="1" valign="top">9.40E-04</td>
<td align="center" colspan="1" rowspan="1" valign="top">2.44E-02</td>
<td align="center" colspan="1" rowspan="1" valign="top">92</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs4746152</td>
<td align="center" colspan="1" rowspan="1" valign="top">5.25E-03</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.37E-04</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">12</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>B4GALNT1</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">7.10E-05</td>
<td align="center" colspan="1" rowspan="1" valign="top">2</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs10083154</td>
<td align="center" colspan="1" rowspan="1" valign="top">3.45E-06</td>
<td align="center" colspan="1" rowspan="1" valign="top">3.98E-02</td>
<td align="center" colspan="1" rowspan="1" valign="top">27</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs715930</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.94E-02</td>
<td align="center" colspan="1" rowspan="1" valign="top">3.89E-05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">12</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>BRAP</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.93E-02</td>
<td align="center" colspan="1" rowspan="1" valign="top">5</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs11065987</td>
<td align="center" colspan="1" rowspan="1" valign="top">3.83E-03</td>
<td align="center" colspan="1" rowspan="1" valign="top">3.96E-04</td>
<td align="center" colspan="1" rowspan="1" valign="top">45</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs11065987</td>
<td align="center" colspan="1" rowspan="1" valign="top">5.05E-05</td>
<td align="center" colspan="1" rowspan="1" valign="top">9.77E-05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">12</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>CLEC2D</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.87E-04</td>
<td align="center" colspan="1" rowspan="1" valign="top">6</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs3764021</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.24E-05</td>
<td align="center" colspan="1" rowspan="1" valign="top">6.40E-03</td>
<td align="center" colspan="1" rowspan="1" valign="top">105</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs7968401</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.53E-04</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.75E-05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">12</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>CLECL1</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">3.16E-04</td>
<td align="center" colspan="1" rowspan="1" valign="top">5</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs10466829</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.09E-05</td>
<td align="center" colspan="1" rowspan="1" valign="top">3.26E-04</td>
<td align="center" colspan="1" rowspan="1" valign="top">106</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs2401391</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.55E-04</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.76E-06</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">12</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>HECTD4</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">3.22E-02</td>
<td align="center" colspan="1" rowspan="1" valign="top">11</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs11066188</td>
<td align="center" colspan="1" rowspan="1" valign="top">2.14E-03</td>
<td align="center" colspan="1" rowspan="1" valign="top">3.16E-04</td>
<td align="center" colspan="1" rowspan="1" valign="top">255</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs10850034</td>
<td align="center" colspan="1" rowspan="1" valign="top">2.49E-05</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.27E-04</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">12</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>NAA25</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.34E-02</td>
<td align="center" colspan="1" rowspan="1" valign="top">7</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs17696736</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.93E-03</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.21E-04</td>
<td align="center" colspan="1" rowspan="1" valign="top">105</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs17696736</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.13E-05</td>
<td align="center" colspan="1" rowspan="1" valign="top">2.32E-05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">12</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>OS9</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">9.80E-05</td>
<td align="center" colspan="1" rowspan="1" valign="top">2</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs799265</td>
<td align="center" colspan="1" rowspan="1" valign="top">7.96E-06</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.38E-02</td>
<td align="center" colspan="1" rowspan="1" valign="top">50</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs76809208</td>
<td align="center" colspan="1" rowspan="1" valign="top">3.47E-03</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.96E-05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">14</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>NUDT14</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">2.29E-02</td>
<td align="center" colspan="1" rowspan="1" valign="top">2</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs11625862</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.60E-02</td>
<td align="center" colspan="1" rowspan="1" valign="top">3.33E-04</td>
<td align="center" colspan="1" rowspan="1" valign="top">26</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs11625865</td>
<td align="center" colspan="1" rowspan="1" valign="top">9.99E-05</td>
<td align="center" colspan="1" rowspan="1" valign="top">9.75E-05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">19</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>PDE4C</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">4.54E-04</td>
<td align="center" colspan="1" rowspan="1" valign="top">7</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs4808762</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.06E-06</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.78E-02</td>
<td align="center" colspan="1" rowspan="1" valign="top">101</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs11667487</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.65E-03</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.03E-04</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">19</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>SLC44A2</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">3.16E-04</td>
<td align="center" colspan="1" rowspan="1" valign="top">4</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs8106664</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.78E-04</td>
<td align="center" colspan="1" rowspan="1" valign="top">5.42E-03</td>
<td align="center" colspan="1" rowspan="1" valign="top">142</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs7250421</td>
<td align="center" colspan="1" rowspan="1" valign="top">5.95E-04</td>
<td align="center" colspan="1" rowspan="1" valign="top">2.45E-05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">20</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>LIME1</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">8.20E-05</td>
<td align="center" colspan="1" rowspan="1" valign="top">2</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs2427536</td>
<td align="center" colspan="1" rowspan="1" valign="top">6.78E-05</td>
<td align="center" colspan="1" rowspan="1" valign="top">8.91E-03</td>
<td align="center" colspan="1" rowspan="1" valign="top">19</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs1056441</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.64E-03</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.11E-05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">20</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>RTEL1</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.76E-04</td>
<td align="center" colspan="1" rowspan="1" valign="top">6</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs6011002</td>
<td align="center" colspan="1" rowspan="1" valign="top">2.36E-04</td>
<td align="center" colspan="1" rowspan="1" valign="top">6.07E-03</td>
<td align="center" colspan="1" rowspan="1" valign="top">192</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs145832440</td>
<td align="center" colspan="1" rowspan="1" valign="top">6.13E-04</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.58E-05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">20</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>RTEL1-TNFRSF6B</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.47E-04</td>
<td align="center" colspan="1" rowspan="1" valign="top">6</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs6011002</td>
<td align="center" colspan="1" rowspan="1" valign="top">2.36E-04</td>
<td align="center" colspan="1" rowspan="1" valign="top">5.58E-03</td>
<td align="center" colspan="1" rowspan="1" valign="top">205</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs145832440</td>
<td align="center" colspan="1" rowspan="1" valign="top">6.13E-04</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.23E-05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">20</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>SLC2A4RG</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">8.60E-05</td>
<td align="center" colspan="1" rowspan="1" valign="top">2</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs2427536</td>
<td align="center" colspan="1" rowspan="1" valign="top">6.78E-05</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.02E-02</td>
<td align="center" colspan="1" rowspan="1" valign="top">20</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs1056441</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.64E-03</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.31E-05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">20</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>ZBTB46</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">3.04E-03</td>
<td align="center" colspan="1" rowspan="1" valign="top">12</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs6062314</td>
<td align="center" colspan="1" rowspan="1" valign="top">8.26E-07</td>
<td align="center" colspan="1" rowspan="1" valign="top">5.42E-03</td>
<td align="center" colspan="1" rowspan="1" valign="top">302</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs150589984</td>
<td align="center" colspan="1" rowspan="1" valign="top">2.18E-04</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.98E-04</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">20</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>ZGPAT</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.46E-03</td>
<td align="center" colspan="1" rowspan="1" valign="top">5</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs1151625</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.04E-04</td>
<td align="center" colspan="1" rowspan="1" valign="top">5.93E-03</td>
<td align="center" colspan="1" rowspan="1" valign="top">98</td>
<td align="center" colspan="1" rowspan="1" valign="top">rs6011040</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.22E-03</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.10E-04</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<attrib>
<italic>Chr, chromosome; SNP, single-nucleotide polymorphism; nSNPs, number of SNPs; TopSNP, the most significant SNP in related gene.</italic>
</attrib>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="S3.SS2">
<title>Differential Expression Analyses of Overlapped Genes</title>
<p>We analyzed and integrated GEO profiles of MS and IS to investigate the differential expression levels of shared genes. Notably, 16 of 24 common genes were determined to have significant changes in at least one of the four GEO data sets with <italic>P</italic> &lt; 2.08E-03 (0.05/24) (<xref ref-type="table" rid="T2">Table 2</xref>).</p>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>The expression alteration of shared gene sets for multiple sclerosis and ischemic stroke.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="2" rowspan="1" valign="top">MS<hr/></td>
<td align="center" colspan="2" rowspan="1" valign="top">IS<hr/></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Gene</td>
<td align="center" colspan="1" rowspan="1" valign="top">GSE21942</td>
<td align="center" colspan="1" rowspan="1" valign="top">GSE43591</td>
<td align="center" colspan="1" rowspan="1" valign="top">GSE16561</td>
<td align="center" colspan="1" rowspan="1" valign="top">GSE58294</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>B4GALNT1</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">8.53E-02</td>
<td align="center" colspan="1" rowspan="1" valign="top">9.83E-02</td>
<td align="center" colspan="1" rowspan="1" valign="top">3.48E-01</td>
<td align="center" colspan="1" rowspan="1" valign="top">2.03E-02</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>BRAP</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">4.87E-01</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.44E-02</td>
<td align="center" colspan="1" rowspan="1" valign="top">4.13E-01</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.71E-20</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>CAMK2G</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">4.15E-04</td>
<td align="center" colspan="1" rowspan="1" valign="top">3.09E-06</td>
<td align="center" colspan="1" rowspan="1" valign="top">5.81E-01</td>
<td align="center" colspan="1" rowspan="1" valign="top">5.14E-07</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>CLEC2D</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">9.11E-04</td>
<td align="center" colspan="1" rowspan="1" valign="top">7.91E-02</td>
<td align="center" colspan="1" rowspan="1" valign="top">2.68E-07</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.78E-01</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>CLECL1</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">7.42E-01</td>
<td align="center" colspan="1" rowspan="1" valign="top">4.19E-01</td>
<td align="center" colspan="1" rowspan="1" valign="top">2.94E-01</td>
<td align="center" colspan="1" rowspan="1" valign="top">6.30E-06</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>FOXP1</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">2.35E-09</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.17E-02</td>
<td align="center" colspan="1" rowspan="1" valign="top">4.27E-02</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.55E-05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>HECTD4</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">7.59E-02</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.34E-02</td>
<td align="center" colspan="1" rowspan="1" valign="top">—</td>
<td align="center" colspan="1" rowspan="1" valign="top">8.83E-05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>IL6</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.27E-02</td>
<td align="center" colspan="1" rowspan="1" valign="top">4.99E-01</td>
<td align="center" colspan="1" rowspan="1" valign="top">9.05E-01</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.02E-01</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>LBH</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">3.52E-02</td>
<td align="center" colspan="1" rowspan="1" valign="top">5.60E-04</td>
<td align="center" colspan="1" rowspan="1" valign="top">5.45E-06</td>
<td align="center" colspan="1" rowspan="1" valign="top">7.92E-01</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>LIME1</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">3.35E-02</td>
<td align="center" colspan="1" rowspan="1" valign="top">9.94E-03</td>
<td align="center" colspan="1" rowspan="1" valign="top">2.33E-07</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.16E-09</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>MICB</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">6.07E-01</td>
<td align="center" colspan="1" rowspan="1" valign="top">2.05E-01</td>
<td align="center" colspan="1" rowspan="1" valign="top">8.59E-01</td>
<td align="center" colspan="1" rowspan="1" valign="top">2.45E-04</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>NAA25</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">2.09E-01</td>
<td align="center" colspan="1" rowspan="1" valign="top">5.01E-02</td>
<td align="center" colspan="1" rowspan="1" valign="top">9.57E-01</td>
<td align="center" colspan="1" rowspan="1" valign="top">3.92E-08</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>NFKBIL1</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">3.63E-01</td>
<td align="center" colspan="1" rowspan="1" valign="top">6.31E-01</td>
<td align="center" colspan="1" rowspan="1" valign="top">2.21E-01</td>
<td align="center" colspan="1" rowspan="1" valign="top">3.33E-06</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>NUDT14</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.51E-04</td>
<td align="center" colspan="1" rowspan="1" valign="top">8.09E-01</td>
<td align="center" colspan="1" rowspan="1" valign="top">9.00E-03</td>
<td align="center" colspan="1" rowspan="1" valign="top">2.53E-02</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>OS9</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">2.99E-01</td>
<td align="center" colspan="1" rowspan="1" valign="top">8.58E-01</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.41E-04</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.24E-12</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>PDE4C</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">2.52E-02</td>
<td align="center" colspan="1" rowspan="1" valign="top">2.01E-01</td>
<td align="center" colspan="1" rowspan="1" valign="top">2.40E-01</td>
<td align="center" colspan="1" rowspan="1" valign="top">8.74E-02</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>RTEL1</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.43E-01</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.73E-01</td>
<td align="center" colspan="1" rowspan="1" valign="top">2.53E-01</td>
<td align="center" colspan="1" rowspan="1" valign="top">8.01E-01</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>RTEL1-TNFRSF6B</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">2.20E-03</td>
<td align="center" colspan="1" rowspan="1" valign="top">9.24E-03</td>
<td align="center" colspan="1" rowspan="1" valign="top">—</td>
<td align="center" colspan="1" rowspan="1" valign="top">5.42E-01</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>SLC2A4RG</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">7.21E-02</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.29E-03</td>
<td align="center" colspan="1" rowspan="1" valign="top">5.07E-05</td>
<td align="center" colspan="1" rowspan="1" valign="top">3.18E-01</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>SLC44A2</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">4.03E-02</td>
<td align="center" colspan="1" rowspan="1" valign="top">9.87E-02</td>
<td align="center" colspan="1" rowspan="1" valign="top">4.73E-04</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.27E-03</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>STAT4</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.47E-01</td>
<td align="center" colspan="1" rowspan="1" valign="top">7.80E-01</td>
<td align="center" colspan="1" rowspan="1" valign="top">3.93E-03</td>
<td align="center" colspan="1" rowspan="1" valign="top">9.05E-01</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>TEC</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">7.27E-01</td>
<td align="center" colspan="1" rowspan="1" valign="top">5.51E-01</td>
<td align="center" colspan="1" rowspan="1" valign="top">4.71E-01</td>
<td align="center" colspan="1" rowspan="1" valign="top">9.03E-02</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ZBTB46</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">5.81E-01</td>
<td align="center" colspan="1" rowspan="1" valign="top">7.17E-01</td>
<td align="center" colspan="1" rowspan="1" valign="top">7.52E-01</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.06E-02</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ZGPAT</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">5.70E-02</td>
<td align="center" colspan="1" rowspan="1" valign="top">6.93E-04</td>
<td align="center" colspan="1" rowspan="1" valign="top">6.20E-03</td>
<td align="center" colspan="1" rowspan="1" valign="top">8.85E-03</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<attrib>
<italic>GEO series, GSE21942, GSE43591, GSE16561, and GSE58294. “—”, data from the related GEO database are not available.</italic>
</attrib>
</table-wrap-foot>
</table-wrap>
<p>In MS expression profiles, the transcriptional levels of <italic>CAMK2G</italic> (<italic>P</italic> = 4.15E-04), <italic>CLEC2D</italic> (<italic>P</italic> = 9.11E-04), <italic>FOXP1</italic> (<italic>P</italic> = 2.35E-09), and <italic>NUDT14</italic> (<italic>P</italic> = 1.51E-04) in the GEO data set GSE21942 (<xref ref-type="supplementary-material" rid="TS2">Supplementary Table S2</xref>) and <italic>CAMK2G</italic> (<italic>P</italic> = 3.09E-06), <italic>LBH</italic> (<italic>P</italic> = 5.60E-04), <italic>SLC2A4RG</italic> (<italic>P</italic> = 1.29E-03), and <italic>ZGPAT</italic> (<italic>P</italic> = 6.93E-04) in MS patients were markedly changed compared to controls (<xref ref-type="supplementary-material" rid="TS3">Supplementary Table S3</xref>). In samples from peripheral whole blood, <italic>CLEC2D</italic> (<italic>P</italic> = 2.68E-07), <italic>LBH</italic> (<italic>P</italic> = 5.45E-06), <italic>LIME1</italic> (<italic>P</italic> = 2.33E-07), <italic>OS9</italic> (<italic>P</italic> = 1.41E-04), <italic>SLC2A4RG</italic> (<italic>P</italic> = 5.07E-05), and <italic>SLC44A2</italic> (<italic>P</italic> = 4.73E-04) in the acute IS case–control set (GSE16561) (<xref ref-type="supplementary-material" rid="TS4">Supplementary Table S4</xref>) and <italic>BRAP</italic> (<italic>P</italic> = 1.71E-20), <italic>CAMK2G</italic> (<italic>P</italic> = 5.14E-07), <italic>CLECL1</italic> (<italic>P</italic> = 6.30E-06), <italic>FOXP1</italic> (<italic>P</italic> = 1.55E-05), <italic>HECTD4</italic> (<italic>P</italic> = 8.83E-05), <italic>LIME1</italic> (<italic>P</italic> = 1.16E-09), <italic>MICB</italic> (<italic>P</italic> = 2.45E-04), <italic>NAA25</italic> (<italic>P</italic> = 3.92E-08), <italic>NFKBIL1</italic> (<italic>P</italic> = 3.33E-06), <italic>OS9</italic> (<italic>P</italic> = 1.24E-12), and <italic>SLC44A2</italic> (<italic>P</italic> = 1.27E-03) in the cardioembolic stroke case–control set (GSE58294) (<xref ref-type="supplementary-material" rid="TS5">Supplementary Table S5</xref>) showed significantly different expression.</p>
<p>It was remarkable that there were five overlapped genes with a significant expressed difference in at least one data set of each disease GEO data sets (<italic>P</italic> &lt; 2.08E-03) (<xref ref-type="table" rid="T3">Table 3</xref>). The expression difference of every individual gene presented the same tendency between two GEO data sets in MS, and <italic>CAMK2G</italic> was also upregulated in IS GEO data sets, whereas three of five genes (<italic>CLEC2D</italic>, <italic>LBH</italic>, and <italic>SLC2A4RG</italic>) had opposite alterations in GSE16561 and GSE58294, which might be due to the heterogeneity of IS and its subtypes. <italic>FOXP1</italic> expression in patients was remarkably increased in every data set compared to controls [GSE21942: log fold change (FC) = 1.21, GSE43591: logFC = 0.528, GSE16561: logFC = 0.15, and GSE58294: logFC = 0.34].</p>
<table-wrap id="T3" position="float">
<label>TABLE 3</label>
<caption>
<p>Significant shared gene sets of multiple sclerosis and ischemic stroke in GEO data sets.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="4" rowspan="1" valign="top">Multiple sclerosis and control<hr/></td>
<td align="center" colspan="4" rowspan="1" valign="top">Ischemic stroke and control<hr/></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Gene</td>
<td align="center" colspan="2" rowspan="1" valign="top">GSE21942<hr/></td>
<td align="center" colspan="2" rowspan="1" valign="top">GSE43591<hr/></td>
<td align="center" colspan="2" rowspan="1" valign="top">GSE16561<hr/></td>
<td align="center" colspan="2" rowspan="1" valign="top">GSE58294<hr/></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top"><italic>P</italic> value</td>
<td align="center" colspan="1" rowspan="1" valign="top">logFC</td>
<td align="center" colspan="1" rowspan="1" valign="top"><italic>P</italic> value</td>
<td align="center" colspan="1" rowspan="1" valign="top">logFC</td>
<td align="center" colspan="1" rowspan="1" valign="top"><italic>P</italic> value</td>
<td align="center" colspan="1" rowspan="1" valign="top">logFC</td>
<td align="center" colspan="1" rowspan="1" valign="top"><italic>P</italic> value</td>
<td align="center" colspan="1" rowspan="1" valign="top">logFC</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>CAMK2G</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<bold>4.15E-04</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">–0.551</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<bold>3.09E-06</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">–0.44</td>
<td align="center" colspan="1" rowspan="1" valign="top">5.81E-01</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.043117</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<bold>5.14E-07</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.352815</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>CLEC2D</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<bold>9.11E-04</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.489</td>
<td align="center" colspan="1" rowspan="1" valign="top">7.91E-02</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.24</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<bold>2.68E-07</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">–0.66082</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.78E-01</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.180726</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>FOXP1</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<bold>2.35E-09</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.21</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.17E-02</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.528</td>
<td align="center" colspan="1" rowspan="1" valign="top">4.27E-02</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.149791</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<bold>1.55E-05</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.339692</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>LBH</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">3.52E-02</td>
<td align="center" colspan="1" rowspan="1" valign="top">–0.321</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<bold>5.60E-04</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">–0.553</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<bold>5.45E-06</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">–0.55397</td>
<td align="center" colspan="1" rowspan="1" valign="top">7.92E-01</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.02761</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>SLC2A4RG</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">7.21E-02</td>
<td align="center" colspan="1" rowspan="1" valign="top">–0.205</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<bold>1.29E-03</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">–0.332</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<bold>5.07E-05</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">–0.24643</td>
<td align="center" colspan="1" rowspan="1" valign="top">3.18E-01</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.07236</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<attrib>
<italic>logFC, log2-fold change. Bolded <italic>P</italic> values of genes achieved Bonferroni-corrected significance, adjusted for the number of shared genes present in each expression data set.</italic>
</attrib>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec id="S4">
<title>Discussion</title>
<p>With the development of high-throughput technology, more risk loci of MS and IS have been gradually identified (<xref ref-type="bibr" rid="B35">International Multiple Sclerosis Genetics Consortium et al., 2013</xref>; <xref ref-type="bibr" rid="B58">Moutsianas et al., 2015</xref>; <xref ref-type="bibr" rid="B51">Malik et al., 2018</xref>). However, genes shared by the two diseases remain elusive. In this study, we implemented a three-part process to assess GWAS data sets. In Part 1, we conducted independent gene-based association analyses using two GWAS data sets and VEGAS2. In Part 2, we performed a Fisher’s meta-analysis of nominally significant common genes (<italic>P-</italic><sub><italic>MS</italic></sub> &lt; 0.05, <italic>P-</italic><sub><italic>IS</italic></sub> &lt; 0.05), and 24 shared genes satisfied the strict threshold <italic>P</italic> value (<italic>P</italic> &lt; 2.31E-04). In Part 3, we listed expression information of shared genes in four GEO data sets and found that <italic>FOXP1</italic>, <italic>CAMK2G</italic>, <italic>CLEC2D</italic>, <italic>LBH</italic>, and <italic>SLC2A4RG</italic> presented significant differential expression in both MS and IS case–control profiles.</p>
<sec id="S4.SS1">
<title><italic>FOXP1</italic> Located at 3p13</title>
<p>Forkhead box protein P1 protein is a member of the forkhead box (FOX) family. The forkhead TF plays vital roles in diverse cell and tissue processes including development, aging, metabolism, and cancer (<xref ref-type="bibr" rid="B17">Coffer and Burgering, 2004</xref>; <xref ref-type="bibr" rid="B79">Wijchers et al., 2006</xref>). <italic>FOXP1</italic> is also critical in the development and function of immune cells. In peritonitis models, <xref ref-type="bibr" rid="B67">Shi et al. (2008)</xref> illustrated that <italic>FOXP1</italic> upregulation blunted monocyte development and macrophage biological activities by inhibiting the production of <italic>c-Fms</italic>/macrophage colony-stimulating factor receptor. Via Smad2/Smad3 and transforming growth factor β (TGF-β) signaling, increased FOXP1 expression restrained CD8<sup>+</sup> T cells from proliferation and activation in cancer (<xref ref-type="bibr" rid="B69">Stephen et al., 2014</xref>). Combined with <italic>FOXP3</italic>, <italic>FOXP1</italic> was demonstrated to play an essential role in maintaining expression of CD25, SATB1, and CTLA-4 and responsiveness to interleukin 2 in regulatory T cells (<xref ref-type="bibr" rid="B43">Konopacki et al., 2019</xref>). <italic>FOXP1</italic> was also reported as a crucial negative transcriptional modulator in the differentiation of CD4<sup>+</sup> follicular helper T cells (<xref ref-type="bibr" rid="B77">Wang et al., 2014</xref>). Similarly, <italic>FOXP1</italic> is a fundamental TF in the early development of B cells (<xref ref-type="bibr" rid="B31">Hu et al., 2006</xref>), and abnormal <italic>FOXP1</italic> upregulation leads to a reduction and irregular distribution of B cells in germinal centers (<xref ref-type="bibr" rid="B66">Sagardoy et al., 2013</xref>). <italic>FOXP1</italic> is associated with both CNS development and abnormalities. <xref ref-type="bibr" rid="B10">Braccioli et al. (2017)</xref> reported that <italic>FOXP1</italic> can adjust neural stem cells (NSCs) neurogenesis via Notch signaling and foster the differentiation of embryonic NSCs to neurons and astrocytes <italic>in vitro</italic>. <xref ref-type="bibr" rid="B45">Li et al. (2015)</xref> demonstrated that <italic>FOXP1</italic> has vital influences on modulating neuronal migration and morphogenesis in cortical regions. <italic>FOXP1</italic> mutations reportedly contribute to nervous system disorders including Huntington disease (<xref ref-type="bibr" rid="B71">Tang et al., 2012</xref>), autism (<xref ref-type="bibr" rid="B60">O’Roak et al., 2011</xref>; <xref ref-type="bibr" rid="B15">Chien et al., 2013</xref>), and epilepsy (<xref ref-type="bibr" rid="B37">Jay et al., 2019</xref>).</p>
<p>In this study, <italic>FOXP1</italic> exhibited an elevated tendency of expression in both MS and IS patients compared to controls (GSE21942: logFC = 1.21; GSE43591: logFC = 0.528; GSE16561: logFC = 0.15, and GSE58294: logFC = 0.34). FOXP1 was significantly more than twofold upregulated in the PBMC of MS (<italic>P</italic> = 2.35E-09, logFC = 1.21) and significantly 1.3-fold upregulated in the blood cells of cardioembolic stroke (<italic>p</italic> = 1.55E-05, logFC = 0.34). The IMSGC assessed two sets of GWAS data and identified rs9828629/FOXP1 (<italic>P</italic> = 1.9E-10, odds ratio [OR] = 1.08) as an immune-related risk variant linked to MS (<xref ref-type="bibr" rid="B35">International Multiple Sclerosis Genetics Consortium et al., 2013</xref>). In research on atherosclerosis, <xref ref-type="bibr" rid="B9">Bot et al. (2011)</xref> illustrated that FOXP1 was expressed in diverse cell types and was related with stable plaques through the TGF-β pathway. As atherosclerosis is one cause of large vessel disease, a major subtype of IS, there may be more associations between FOXP1 and IS. In summary, <italic>FOXP1</italic> could be a potential target in terms of its multiple functions in the immune and nervous systems.</p>
</sec>
<sec id="S4.SS2">
<title><italic>CAMK2G</italic> Located at 10q22.2</title>
<p><italic>CAMK2G</italic> encodes CaMKIIγ, an isoform of calcium (Ca<sup>2+</sup>)/calmodulin-dependent protein kinase II (CaMKII) that participates in Ca<sup>2+</sup>-related biological activities (<xref ref-type="bibr" rid="B32">Hudmon et al., 2001</xref>; <xref ref-type="bibr" rid="B63">Rokita and Anderson, 2012</xref>). In a model of acute ischemia/reperfusion, <italic>CAMK2G</italic>/CaMKIIγ improved neuronal survival by activating nuclear factor κB signaling (<xref ref-type="bibr" rid="B81">Ye et al., 2019</xref>). <italic>CAMK2G</italic> was identified as an enhancer gene for coronary artery disease in a GWAS meta-analysis (<xref ref-type="bibr" rid="B29">Gong et al., 2018</xref>). CAMKIIγ was also a key modulator to repress macrophage phagocytosis and enhance the necrosis of atherosclerotic plaques (<xref ref-type="bibr" rid="B22">Doran et al., 2017</xref>). We found that <italic>CAMK2G</italic> (<italic>P</italic> = 5.14E-07) was 1.3-fold upregulated in cardioembolic stroke compared to controls. In addition, <italic>CAMK2G</italic> could act through classical inflammatory pathways such as mTORC1 and STAT3, both of which play vital roles in MS (<xref ref-type="bibr" rid="B50">Ma et al., 2017</xref>; <xref ref-type="bibr" rid="B55">Meng et al., 2017</xref>).</p>
</sec>
<sec id="S4.SS3">
<title><italic>CLEC2D</italic> Located at 12p13.31</title>
<p><italic>CLEC2D</italic> encodes lectin-like transcript 1 (LLT1) and is located next to the NK gene complex (<xref ref-type="bibr" rid="B82">Yokoyama and Plougastel, 2003</xref>; <xref ref-type="bibr" rid="B27">Germain et al., 2010</xref>). LLT1 was identified as a negative ligand for NKR-P1A (CD161) receptor in humans (<xref ref-type="bibr" rid="B64">Rosen et al., 2005</xref>). The interaction of CD161 on NK cells with matched LLT1 can reportedly repress NK cell-mediated cytotoxicity (<xref ref-type="bibr" rid="B3">Aldemir et al., 2005</xref>). <xref ref-type="bibr" rid="B49">Llibre et al. (2016)</xref> illustrated that LLT1/CD161 interaction influences B-cell development in human germinal centers. Toll-like receptor (TLR)-activated dendritic cells and TLR or B-cell receptor-activated B cells express LLT1 (<xref ref-type="bibr" rid="B65">Rosen et al., 2008</xref>). LLT1 is also expressed by monocyte/macrophage in RA joints, and soluble LLT1 is elevated in patient serum (<xref ref-type="bibr" rid="B11">Chalan et al., 2015</xref>). Here, we detected that the expression of <italic>CLEC2D</italic> (<italic>P</italic> = 9.11E-04, logFC = 0.49) was significantly altered in PBMCs from MS patients. However, the expression of <italic>CLEC2D</italic> in IS cases was downregulated by 0.62-fold compared to controls. The distinct alterations of <italic>CLEC2D</italic> expression in MS and IS need further study.</p>
</sec>
<sec id="S4.SS4">
<title><italic>SLC2A4RG</italic> Located at 20q13.33</title>
<p>SLC2A4 regulator encoded by <italic>SLC2A4RG</italic> was identified as TF binding to the SLC2A4 promoter district where it regulates expression (<xref ref-type="bibr" rid="B61">Oshel et al., 2000</xref>; <xref ref-type="bibr" rid="B42">Knight et al., 2003</xref>). In a study of Huntington disease, <italic>SLC2A4RG</italic> was found to cooperate with a key <italic>cis</italic>-element and shuttle to and from the nucleus (<xref ref-type="bibr" rid="B70">Tanaka et al., 2004</xref>). A recent large GWAS demonstrated that rs2256814/<italic>SLC2A4RG</italic> (<italic>P</italic> = 3.5E-9, OR = 1.08) was a novel MS susceptibility gene with immune function (<xref ref-type="bibr" rid="B35">International Multiple Sclerosis Genetics Consortium et al., 2013</xref>). Furthermore, <xref ref-type="bibr" rid="B20">Dhaouadi et al. (2014)</xref> stated that SLC2A4RG could slightly induce TGFB1 expression in atherosclerosis. Notably, SLC2A4RG showed differential expression in MS and IS GEO data sets (GSE43591, <italic>P</italic> = 1.29E-03; GSE16561, <italic>P</italic> = 5.07E-05).</p>
</sec>
<sec id="S4.SS5">
<title><italic>LBH</italic> Located at 2p23.1</title>
<p>Limb-bud and heart (<italic>LBH</italic>) encodes a transcription modulator that regulates cell development in multiple tissues (<xref ref-type="bibr" rid="B1">Ai et al., 2008</xref>; <xref ref-type="bibr" rid="B2">Al-Ali et al., 2010</xref>; <xref ref-type="bibr" rid="B23">Ekwall et al., 2015</xref>). <italic>LBH</italic> and related variants are reportedly associated with autoimmune diseases such as SLE, RA, and celiac disease (<xref ref-type="bibr" rid="B85">Zhernakova et al., 2011</xref>; <xref ref-type="bibr" rid="B84">Yu et al., 2013</xref>; <xref ref-type="bibr" rid="B13">Chang et al., 2016</xref>). Wnt signaling regulates the expression of <italic>LBH</italic> in tumors and the epithelium (<xref ref-type="bibr" rid="B62">Rieger et al., 2010</xref>). In the CNS, the Wnt pathway is related with male-specific genes of IS and positively impacts the regenerative process after injury (<xref ref-type="bibr" rid="B73">Tian et al., 2012</xref>; <xref ref-type="bibr" rid="B44">Lambert et al., 2016</xref>). Researchers integrated Alzheimer’s disease-GWAS data and identified <italic>LBH</italic> as a pathogenic gene of amyloid β accumulation that is tightly linked to immune system (<xref ref-type="bibr" rid="B56">Mhatre et al., 2015</xref>; <xref ref-type="bibr" rid="B80">Yamaguchi-Kabata et al., 2018</xref>). In our study, <italic>LBH</italic> was significantly downregulated both in T cells from PBMCs of patients with MS (<italic>P</italic> = 5.60E-04, logFC = −0.55) and blood cells from patients with IS (<italic>P</italic> = 5.45E-06, logFC = −0.55). The potential immunomodulatory function of <italic>LBH</italic> can assist us in uncovering common mechanisms between MS and IS.</p>
<p>Although we conducted powerful gene-based tests that are effective extensions of traditional GWASs to discover shared genes, our study has several limitations. First, subthreshold variants will undermine the significance of the causal SNPs in the same gene region. Next, IS consists of several subtypes with genetic heterogeneity. More refined data of IS subtypes should be excavated for further analyses. Furthermore, the single sample type and limited case numbers are two major disadvantages of our GEO data. All GEO sample sources are from peripheral blood cells because they are safe and accessible in clinical settings. If possible, we will integrate brain-derived data that can directly reflect the differential expression of genes in neurological diseases.</p>
</sec>
</sec>
<sec id="S5">
<title>Conclusion</title>
<p>In summary, we performed flexible gene-based analysis to discover significant shared genes between MS and IS and analyzed their differential expression. These genes mainly participate in cell development and immune response, and both are associated with MS and IS. Our research reveals shared genetic etiologies between MS and IS and indicates new directions for future studies examining mechanisms and new therapeutic options.</p>
</sec>
<sec id="S6" sec-type="data-availability">
<title>Data Availability Statement</title>
<p>All datasets analyzed for this study are included in the article and the <xref ref-type="supplementary-material" rid="TS1">Supplementary Files</xref>.</p>
</sec>
<sec id="S7">
<title>Author Contributions</title>
<p>ZT and ZW conceived and designed the study for MS and IS. ZT administered the analyses and wrote the manuscript. YS and ZG was responsible for manuscript revision. YY and JG provided analyses support. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec id="conf1">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> This work was supported by the fund from the Tianjin Health Bureau (2015KZ035), the National Natural Science Foundation Youth Fund of China (31300923), and In-hospital Science and Technology Fund of Tianjin First Central Hospital.</p>
</fn>
</fn-group>
<fn-group>
<fn id="footnote1">
<label>1</label>
<p>
<ext-link ext-link-type="uri" xlink:href="http://www.r-project.org/">http://www.r-project.org/</ext-link>
</p>
</fn>
<fn id="footnote2">
<label>2</label>
<p>
<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo">www.ncbi.nlm.nih.gov/geo</ext-link>
</p>
</fn>
</fn-group>
<sec id="S9" sec-type="supplementary material">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fgene.2020.00646/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fgene.2020.00646/full#supplementary-material</ext-link></p>
<supplementary-material content-type="local-data" id="TS1">
<label>TABLE S1</label>
<caption>
<p>MS-associated genes with gene-wide significance.</p>
</caption>
<media xlink:href="Table_1.XLSX">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="TS2">
<label>TABLE S2</label>
<caption>
<p>The expression data of shares gene sets from peripheral blood mononuclear cells in multiple sclerosis patients and controls (Series GSE21942).</p>
</caption>
<media xlink:href="Table_2.XLSX">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="TS3">
<label>TABLE S3</label>
<caption>
<p>The expression data of shares gene sets from peripheral blood T-cells in multiple sclerosis patients and controls (Series GSE43591).</p>
</caption>
<media xlink:href="Table_3.XLSX">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="TS4">
<label>TABLE S4</label>
<caption>
<p>The expression data of shares gene sets from whole blood RNA in ischemic stroke patients and controls (Series GSE16561).</p>
</caption>
<media xlink:href="Table_4.XLSX">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="TS5">
<label>TABLE S5</label>
<caption>
<p>The expression data of shares gene sets from whole blood RNA in cardioembolic stroke patients and controls (Series GSE58294).</p>
</caption>
<media xlink:href="Table_5.XLSX">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ai</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Tan</surname><given-names>K.</given-names></name><name><surname>Deng</surname><given-names>Y.</given-names></name><name><surname>Luo</surname><given-names>N.</given-names></name><name><surname>Yuan</surname><given-names>W.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>A human homolog of mouse Lbh gene, hLBH, expresses in heart and activates SRE and AP-1 mediated MAPK signaling pathway.</article-title>
<source/><italic>Mol. Biol. Rep.</italic>
<volume>35</volume>
<fpage>179</fpage>–<lpage>187</lpage>. <pub-id pub-id-type="doi">10.1007/s11033-007-9068-4</pub-id>
<pub-id pub-id-type="pmid">17390236</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Ali</surname><given-names>H.</given-names></name><name><surname>Rieger</surname><given-names>M. E.</given-names></name><name><surname>Seldeen</surname><given-names>K. L.</given-names></name><name><surname>Harris</surname><given-names>T. K.</given-names></name><name><surname>Farooq</surname><given-names>A.</given-names></name><name><surname>Briegel</surname><given-names>K. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Biophysical characterization reveals structural disorder in the developmental transcriptional regulator LBH.</article-title>
<source/><italic>Biochem. Biophys. Res. Commun.</italic>
<volume>391</volume>
<fpage>1104</fpage>–<lpage>1109</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2009.12.032</pub-id>
<pub-id pub-id-type="pmid">20005203</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aldemir</surname><given-names>H.</given-names></name><name><surname>Prod’homme</surname><given-names>V.</given-names></name><name><surname>Dumaurier</surname><given-names>M. J.</given-names></name><name><surname>Retiere</surname><given-names>C.</given-names></name><name><surname>Poupon</surname><given-names>G.</given-names></name><name><surname>Cazareth</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Cutting edge: lectin-like transcript 1 is a ligand for the CD161 receptor.</article-title>
<source/><italic>J. Immunol.</italic>
<volume>175</volume>
<fpage>7791</fpage>–<lpage>7795</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.175.12.7791</pub-id>
<pub-id pub-id-type="pmid">16339512</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baecher-Allan</surname><given-names>C.</given-names></name><name><surname>Kaskow</surname><given-names>B. J.</given-names></name><name><surname>Weiner</surname><given-names>H. L.</given-names></name></person-group> (<year>2018</year>). <article-title>Multiple sclerosis: mechanisms and immunotherapy.</article-title>
<source/><italic>Neuron</italic>
<volume>97</volume>
<fpage>742</fpage>–<lpage>768</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2018.01.021</pub-id>
<pub-id pub-id-type="pmid">29470968</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrett</surname><given-names>T.</given-names></name><name><surname>Wilhite</surname><given-names>S. E.</given-names></name><name><surname>Ledoux</surname><given-names>P.</given-names></name><name><surname>Evangelista</surname><given-names>C.</given-names></name><name><surname>Kim</surname><given-names>I. F.</given-names></name><name><surname>Tomashevsky</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>NCBI GEO: archive for functional genomics data sets–update.</article-title>
<source/><italic>Nucleic Acids Res.</italic>
<volume>41</volume>
<fpage>D991</fpage>–<lpage>D995</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gks1193</pub-id>
<pub-id pub-id-type="pmid">23193258</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Begum</surname><given-names>F.</given-names></name><name><surname>Ghosh</surname><given-names>D.</given-names></name><name><surname>Tseng</surname><given-names>G. C.</given-names></name><name><surname>Feingold</surname><given-names>E.</given-names></name></person-group> (<year>2012</year>). <article-title>Comprehensive literature review and statistical considerations for GWAS meta-analysis.</article-title>
<source/><italic>Nucleic Acids Res.</italic>
<volume>40</volume>
<fpage>3777</fpage>–<lpage>3784</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkr1255</pub-id>
<pub-id pub-id-type="pmid">22241776</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belbasis</surname><given-names>L.</given-names></name><name><surname>Bellou</surname><given-names>V.</given-names></name><name><surname>Evangelou</surname><given-names>E.</given-names></name><name><surname>Ioannidis</surname><given-names>J. P.</given-names></name><name><surname>Tzoulaki</surname><given-names>I.</given-names></name></person-group> (<year>2015</year>). <article-title>Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses.</article-title>
<source/><italic>Lancet Neurol.</italic>
<volume>14</volume>
<fpage>263</fpage>–<lpage>273</lpage>. <pub-id pub-id-type="doi">10.1016/s1474-4422(14)70267-4</pub-id><pub-id pub-id-type="pmid">25662901</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellenguez</surname><given-names>C.</given-names></name><name><surname>Bevan</surname><given-names>S.</given-names></name><name><surname>Gschwendtner</surname><given-names>A.</given-names></name><name><surname>Spencer</surname><given-names>C. C.</given-names></name><name><surname>Burgess</surname><given-names>A. I.</given-names></name><name><surname>Pirinen</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>44</volume>
<fpage>328</fpage>–<lpage>333</lpage>. <pub-id pub-id-type="doi">10.1038/ng.1081</pub-id>
<pub-id pub-id-type="pmid">22306652</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bot</surname><given-names>P. T.</given-names></name><name><surname>Grundmann</surname><given-names>S.</given-names></name><name><surname>Goumans</surname><given-names>M. J.</given-names></name><name><surname>de Kleijn</surname><given-names>D.</given-names></name><name><surname>Moll</surname><given-names>F.</given-names></name><name><surname>de Boer</surname><given-names>O.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Forkhead box protein P1 as a downstream target of transforming growth factor-beta induces collagen synthesis and correlates with a more stable plaque phenotype.</article-title>
<source/><italic>Atherosclerosis</italic>
<volume>218</volume>
<fpage>33</fpage>–<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2011.05.017</pub-id>
<pub-id pub-id-type="pmid">21683954</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braccioli</surname><given-names>L.</given-names></name><name><surname>Vervoort</surname><given-names>S. J.</given-names></name><name><surname>Adolfs</surname><given-names>Y.</given-names></name><name><surname>Heijnen</surname><given-names>C. J.</given-names></name><name><surname>Basak</surname><given-names>O.</given-names></name><name><surname>Pasterkamp</surname><given-names>R. J.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>FOXP1 promotes embryonic neural stem cell differentiation by repressing Jagged1 expression.</article-title>
<source/><italic>Stem Cell Rep.</italic>
<volume>9</volume>
<fpage>1530</fpage>–<lpage>1545</lpage>. <pub-id pub-id-type="doi">10.1016/j.stemcr.2017.10.012</pub-id>
<pub-id pub-id-type="pmid">29141232</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chalan</surname><given-names>P.</given-names></name><name><surname>Bijzet</surname><given-names>J.</given-names></name><name><surname>Huitema</surname><given-names>M. G.</given-names></name><name><surname>Kroesen</surname><given-names>B. J.</given-names></name><name><surname>Brouwer</surname><given-names>E.</given-names></name><name><surname>Boots</surname><given-names>A. M.</given-names></name></person-group> (<year>2015</year>). <article-title>Expression of lectin-like transcript 1, the ligand for CD161, in rheumatoid arthritis.</article-title>
<source/><italic>PLoS One</italic>
<volume>10</volume>:<issue>e0132436</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0132436</pub-id>
<pub-id pub-id-type="pmid">26147876</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chamorro</surname><given-names>A.</given-names></name><name><surname>Dirnagl</surname><given-names>U.</given-names></name><name><surname>Urra</surname><given-names>X.</given-names></name><name><surname>Planas</surname><given-names>A. M.</given-names></name></person-group> (<year>2016</year>). <article-title>Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation.</article-title>
<source/><italic>Lancet Neurol.</italic>
<volume>15</volume>
<fpage>869</fpage>–<lpage>881</lpage>. <pub-id pub-id-type="doi">10.1016/s1474-4422(16)00114-9</pub-id><pub-id pub-id-type="pmid">27180033</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>Y.</given-names></name><name><surname>Sheng</surname><given-names>Y.</given-names></name><name><surname>Cheng</surname><given-names>Y.</given-names></name><name><surname>Lin</surname><given-names>Y.</given-names></name><name><surname>Zhu</surname><given-names>Z.</given-names></name><name><surname>Wen</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Downregulated expression of LBH mRNA in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.</article-title>
<source/><italic>J. Dermatol.</italic>
<volume>43</volume>
<fpage>99</fpage>–<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1111/1346-8138.13006</pub-id>
<pub-id pub-id-type="pmid">26134586</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chanvillard</surname><given-names>C.</given-names></name><name><surname>Jacolik</surname><given-names>R. F.</given-names></name><name><surname>Infante-Duarte</surname><given-names>C.</given-names></name><name><surname>Nayak</surname><given-names>R. C.</given-names></name></person-group> (<year>2013</year>). <article-title>The role of natural killer cells in multiple sclerosis and their therapeutic implications.</article-title>
<source/><italic>Front. Immunol.</italic>
<volume>4</volume>:<issue>63</issue>. <pub-id pub-id-type="doi">10.3389/fimmu.2013.00063</pub-id>
<pub-id pub-id-type="pmid">23493880</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chien</surname><given-names>W. H.</given-names></name><name><surname>Gau</surname><given-names>S. S.</given-names></name><name><surname>Chen</surname><given-names>C. H.</given-names></name><name><surname>Tsai</surname><given-names>W. C.</given-names></name><name><surname>Wu</surname><given-names>Y. Y.</given-names></name><name><surname>Chen</surname><given-names>P. H.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Increased gene expression of <italic>FOXP1</italic> in patients with autism spectrum disorders.</article-title>
<source/><italic>Mol. Autism</italic>
<volume>4</volume>:<issue>23</issue>. <pub-id pub-id-type="doi">10.1186/2040-2392-4-23</pub-id>
<pub-id pub-id-type="pmid">23815876</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christoforou</surname><given-names>A.</given-names></name><name><surname>Dondrup</surname><given-names>M.</given-names></name><name><surname>Mattingsdal</surname><given-names>M.</given-names></name><name><surname>Mattheisen</surname><given-names>M.</given-names></name><name><surname>Giddaluru</surname><given-names>S.</given-names></name><name><surname>Nothen</surname><given-names>M. M.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Linkage-disequilibrium-based binning affects the interpretation of GWASs.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>90</volume>
<fpage>727</fpage>–<lpage>733</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2012.02.025</pub-id>
<pub-id pub-id-type="pmid">22444669</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coffer</surname><given-names>P. J.</given-names></name><name><surname>Burgering</surname><given-names>B. M.</given-names></name></person-group> (<year>2004</year>). <article-title>Forkhead-box transcription factors and their role in the immune system.</article-title>
<source/><italic>Nat. Rev. Immunol.</italic>
<volume>4</volume>
<fpage>889</fpage>–<lpage>899</lpage>. <pub-id pub-id-type="doi">10.1038/nri1488</pub-id>
<pub-id pub-id-type="pmid">15516968</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Compston</surname><given-names>A.</given-names></name><name><surname>Coles</surname><given-names>A.</given-names></name></person-group> (<year>2008</year>). <article-title>Multiple sclerosis.</article-title>
<source/><italic>Lancet</italic>
<volume>372</volume>
<fpage>1502</fpage>–<lpage>1517</lpage>.<pub-id pub-id-type="pmid">18970977</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dendrou</surname><given-names>C. A.</given-names></name><name><surname>Fugger</surname><given-names>L.</given-names></name><name><surname>Friese</surname><given-names>M. A.</given-names></name></person-group> (<year>2015</year>). <article-title>Immunopathology of multiple sclerosis.</article-title>
<source/><italic>Nat. Rev. Immunol.</italic>
<volume>15</volume>
<fpage>545</fpage>–<lpage>558</lpage>. <pub-id pub-id-type="doi">10.1038/nri3871</pub-id>
<pub-id pub-id-type="pmid">26250739</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhaouadi</surname><given-names>N.</given-names></name><name><surname>Li</surname><given-names>J. Y.</given-names></name><name><surname>Feugier</surname><given-names>P.</given-names></name><name><surname>Gustin</surname><given-names>M. P.</given-names></name><name><surname>Dab</surname><given-names>H.</given-names></name><name><surname>Kacem</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Computational identification of potential transcriptional regulators of TGF-ss1 in human atherosclerotic arteries.</article-title>
<source/><italic>Genomics</italic>
<volume>103</volume>
<fpage>357</fpage>–<lpage>370</lpage>. <pub-id pub-id-type="doi">10.1016/j.ygeno.2014.05.001</pub-id>
<pub-id pub-id-type="pmid">24819318</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dichgans</surname><given-names>M.</given-names></name><name><surname>Pulit</surname><given-names>S. L.</given-names></name><name><surname>Rosand</surname><given-names>J.</given-names></name></person-group> (<year>2019</year>). <article-title>Stroke genetics: discovery, biology, and clinical applications.</article-title>
<source/><italic>Lancet Neurol.</italic>
<volume>18</volume>
<fpage>587</fpage>–<lpage>599</lpage>. <pub-id pub-id-type="doi">10.1016/s1474-4422(19)30043-2</pub-id><pub-id pub-id-type="pmid">30975520</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doran</surname><given-names>A. C.</given-names></name><name><surname>Ozcan</surname><given-names>L.</given-names></name><name><surname>Cai</surname><given-names>B.</given-names></name><name><surname>Zheng</surname><given-names>Z.</given-names></name><name><surname>Fredman</surname><given-names>G.</given-names></name><name><surname>Rymond</surname><given-names>C. C.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>CAMKIIgamma suppresses an efferocytosis pathway in macrophages and promotes atherosclerotic plaque necrosis.</article-title>
<source/><italic>J. Clin. Invest.</italic>
<volume>127</volume>
<fpage>4075</fpage>–<lpage>4089</lpage>. <pub-id pub-id-type="doi">10.1172/jci94735</pub-id>
<pub-id pub-id-type="pmid">28972541</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ekwall</surname><given-names>A. K.</given-names></name><name><surname>Whitaker</surname><given-names>J. W.</given-names></name><name><surname>Hammaker</surname><given-names>D.</given-names></name><name><surname>Bugbee</surname><given-names>W. D.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Firestein</surname><given-names>G. S.</given-names></name></person-group> (<year>2015</year>). <article-title>The rheumatoid arthritis risk gene LBH regulates growth in fibroblast-like synoviocytes.</article-title>
<source/><italic>Arthritis Rheumatol.</italic>
<volume>67</volume>
<fpage>1193</fpage>–<lpage>1202</lpage>. <pub-id pub-id-type="doi">10.1002/art.39060</pub-id>
<pub-id pub-id-type="pmid">25707478</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elkins</surname><given-names>J.</given-names></name><name><surname>Veltkamp</surname><given-names>R.</given-names></name><name><surname>Montaner</surname><given-names>J.</given-names></name><name><surname>Johnston</surname><given-names>S. C.</given-names></name><name><surname>Singhal</surname><given-names>A. B.</given-names></name><name><surname>Becker</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Safety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind phase 2 trial.</article-title>
<source/><italic>Lancet Neurol.</italic>
<volume>16</volume>
<fpage>217</fpage>–<lpage>226</lpage>. <pub-id pub-id-type="doi">10.1016/s1474-4422(16)30357-x</pub-id><pub-id pub-id-type="pmid">28229893</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>Q.</given-names></name><name><surname>Anrather</surname><given-names>J.</given-names></name><name><surname>Shi</surname><given-names>F. D.</given-names></name></person-group> (<year>2015</year>). <article-title>Immune interventions in stroke.</article-title>
<source/><italic>Nat. Rev. Neurol.</italic>
<volume>11</volume>
<fpage>524</fpage>–<lpage>535</lpage>. <pub-id pub-id-type="doi">10.1038/nrneurol.2015.144</pub-id>
<pub-id pub-id-type="pmid">26303850</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gan</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>Q.</given-names></name><name><surname>Wu</surname><given-names>W.</given-names></name><name><surname>Yin</surname><given-names>J. X.</given-names></name><name><surname>Bai</surname><given-names>X. F.</given-names></name><name><surname>Shen</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Ischemic neurons recruit natural killer cells that accelerate brain infarction.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>111</volume>
<fpage>2704</fpage>–<lpage>2709</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1315943111</pub-id>
<pub-id pub-id-type="pmid">24550298</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Germain</surname><given-names>C.</given-names></name><name><surname>Bihl</surname><given-names>F.</given-names></name><name><surname>Zahn</surname><given-names>S.</given-names></name><name><surname>Poupon</surname><given-names>G.</given-names></name><name><surname>Dumaurier</surname><given-names>M. J.</given-names></name><name><surname>Rampanarivo</surname><given-names>H. H.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Characterization of alternatively spliced transcript variants of CLEC2D gene.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>285</volume>
<fpage>36207</fpage>–<lpage>36215</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M110.179622</pub-id>
<pub-id pub-id-type="pmid">20843815</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gladstone</surname><given-names>D. J.</given-names></name><name><surname>Black</surname><given-names>S. E.</given-names></name><name><surname>Hakim</surname><given-names>A. M.</given-names></name></person-group> (<year>2002</year>). <article-title>Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions.</article-title>
<source/><italic>Stroke</italic>
<volume>33</volume>
<fpage>2123</fpage>–<lpage>2136</lpage>. <pub-id pub-id-type="doi">10.1161/01.str.0000025518.34157.51</pub-id><pub-id pub-id-type="pmid">12154275</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>J.</given-names></name><name><surname>Qiu</surname><given-names>C.</given-names></name><name><surname>Huang</surname><given-names>D.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Yu</surname><given-names>S.</given-names></name><name><surname>Zeng</surname><given-names>C.</given-names></name></person-group> (<year>2018</year>). <article-title>Integrative functional analysis of super enhancer SNPs for coronary artery disease.</article-title>
<source/><italic>J. Hum. Genet.</italic>
<volume>63</volume>
<fpage>627</fpage>–<lpage>638</lpage>. <pub-id pub-id-type="doi">10.1038/s10038-018-0422-2</pub-id>
<pub-id pub-id-type="pmid">29491472</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>Y.</given-names></name><name><surname>Tang</surname><given-names>H. R.</given-names></name><name><surname>Ma</surname><given-names>M.</given-names></name><name><surname>Chen</surname><given-names>N.</given-names></name><name><surname>Xie</surname><given-names>X.</given-names></name><name><surname>He</surname><given-names>L.</given-names></name></person-group> (<year>2019</year>). <article-title>Multiple sclerosis and stroke: a systematic review and meta-analysis.</article-title>
<source/><italic>BMC Neurol.</italic>
<volume>19</volume>:<issue>139</issue>. <pub-id pub-id-type="doi">10.1186/s12883-019-1366-7</pub-id>
<pub-id pub-id-type="pmid">31234793</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>B.</given-names></name><name><surname>Borde</surname><given-names>M.</given-names></name><name><surname>Nardone</surname><given-names>J.</given-names></name><name><surname>Maika</surname><given-names>S.</given-names></name><name><surname>Allred</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Foxp1 is an essential transcriptional regulator of B cell development.</article-title>
<source/><italic>Nat. Immunol.</italic>
<volume>7</volume>
<fpage>819</fpage>–<lpage>826</lpage>. <pub-id pub-id-type="doi">10.1038/ni1358</pub-id>
<pub-id pub-id-type="pmid">16819554</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hudmon</surname><given-names>A.</given-names></name><name><surname>Kim</surname><given-names>S. A.</given-names></name><name><surname>Kolb</surname><given-names>S. J.</given-names></name><name><surname>Stoops</surname><given-names>J. K.</given-names></name><name><surname>Waxham</surname><given-names>M. N.</given-names></name></person-group> (<year>2001</year>). <article-title>Light scattering and transmission electron microscopy studies reveal a mechanism for calcium/calmodulin-dependent protein kinase II self-association.</article-title>
<source/><italic>J. Neurochem.</italic>
<volume>76</volume>
<fpage>1364</fpage>–<lpage>1375</lpage>. <pub-id pub-id-type="doi">10.1046/j.1471-4159.2001.00119.x</pub-id>
<pub-id pub-id-type="pmid">11238721</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><collab>International Multiple Sclerosis Genetics Consortium</collab> (<year>2013</year>). <article-title>Network-based multiple sclerosis pathway analysis with GWAS data from 15,000 cases and 30,000 controls.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>92</volume>
<fpage>854</fpage>–<lpage>865</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2013.04.019</pub-id>
<pub-id pub-id-type="pmid">23731539</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><collab>International Multiple Sclerosis Genetics Consortium</collab> (<year>2019</year>). <article-title>Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility.</article-title>
<source/><italic>Science</italic>
<volume>365</volume>:<issue>eaav7188</issue>. <pub-id pub-id-type="doi">10.1126/science.aav7188</pub-id>
<pub-id pub-id-type="pmid">31604244</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>International Multiple Sclerosis Genetics Consortium, Beecham</surname><given-names>A. H.</given-names></name><name><surname>Patsopoulos</surname><given-names>N. A.</given-names></name><name><surname>Xifara</surname><given-names>D. K.</given-names></name><name><surname>Davis</surname><given-names>M. F.</given-names></name><name><surname>Kemppinen</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>45</volume>
<fpage>1353</fpage>–<lpage>1360</lpage>. <pub-id pub-id-type="doi">10.1038/ng.2770</pub-id>
<pub-id pub-id-type="pmid">24076602</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>International Multiple Sclerosis Genetics Consortium, Wellcome Trust Case Control Consortium, Sawcer</surname><given-names>S.</given-names></name><name><surname>Hellenthal</surname><given-names>G.</given-names></name><name><surname>Pirinen</surname><given-names>M.</given-names></name><name><surname>Spencer</surname><given-names>C. C.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.</article-title>
<source/><italic>Nature</italic>
<volume>476</volume>
<fpage>214</fpage>–<lpage>219</lpage>. <pub-id pub-id-type="doi">10.1038/nature10251</pub-id>
<pub-id pub-id-type="pmid">21833088</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jay</surname><given-names>K.</given-names></name><name><surname>Mitra</surname><given-names>A.</given-names></name><name><surname>Harding</surname><given-names>T.</given-names></name><name><surname>Matthes</surname><given-names>D.</given-names></name><name><surname>Van Ness</surname><given-names>B.</given-names></name></person-group> (<year>2019</year>). <article-title>Identification of a de novo FOXP1 mutation and incidental discovery of inherited genetic variants contributing to a case of autism spectrum disorder and epilepsy.</article-title>
<source/><italic>Mol. Genet. Genomic Med.</italic>
<volume>7</volume>:<issue>e00751</issue>. <pub-id pub-id-type="doi">10.1002/mgg3.751</pub-id>
<pub-id pub-id-type="pmid">31111659</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jernas</surname><given-names>M.</given-names></name><name><surname>Malmestrom</surname><given-names>C.</given-names></name><name><surname>Axelsson</surname><given-names>M.</given-names></name><name><surname>Nookaew</surname><given-names>I.</given-names></name><name><surname>Wadenvik</surname><given-names>H.</given-names></name><name><surname>Lycke</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>microRNA regulate immune pathways in T-cells in multiple sclerosis (MS).</article-title>
<source/><italic>BMC Immunol.</italic>
<volume>14</volume>:<issue>32</issue>. <pub-id pub-id-type="doi">10.1186/1471-2172-14-32</pub-id>
<pub-id pub-id-type="pmid">23895517</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>W.</given-names></name><name><surname>Onuma</surname><given-names>O.</given-names></name><name><surname>Owolabi</surname><given-names>M.</given-names></name><name><surname>Sachdev</surname><given-names>S.</given-names></name></person-group> (<year>2016</year>). <article-title>Stroke: a global response is needed.</article-title>
<source/><italic>Bull. World Health Organ.</italic>
<volume>94</volume>
<fpage>634</fpage>–<lpage>634A</lpage>. <pub-id pub-id-type="doi">10.2471/blt.16.181636</pub-id>
<pub-id pub-id-type="pmid">27708464</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kemppinen</surname><given-names>A. K.</given-names></name><name><surname>Kaprio</surname><given-names>J.</given-names></name><name><surname>Palotie</surname><given-names>A.</given-names></name><name><surname>Saarela</surname><given-names>J.</given-names></name></person-group> (<year>2011</year>). <article-title>Systematic review of genome-wide expression studies in multiple sclerosis.</article-title>
<source/><italic>BMJ Open</italic>
<volume>1</volume>:<issue>e000053</issue>. <pub-id pub-id-type="doi">10.1136/bmjopen-2011-000053</pub-id>
<pub-id pub-id-type="pmid">22021740</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>N. A.</given-names></name><name><surname>Quan</surname><given-names>H.</given-names></name><name><surname>Hill</surname><given-names>M. D.</given-names></name><name><surname>Pilote</surname><given-names>L.</given-names></name><name><surname>McAlister</surname><given-names>F. A.</given-names></name><name><surname>Palepu</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Risk factors, quality of care and prognosis in South Asian, East Asian and White patients with stroke.</article-title>
<source/><italic>BMC Neurol.</italic>
<volume>13</volume>:<issue>74</issue>. <pub-id pub-id-type="doi">10.1186/1471-2377-13-74</pub-id>
<pub-id pub-id-type="pmid">23829874</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knight</surname><given-names>J. B.</given-names></name><name><surname>Eyster</surname><given-names>C. A.</given-names></name><name><surname>Griesel</surname><given-names>B. A.</given-names></name><name><surname>Olson</surname><given-names>A. L.</given-names></name></person-group> (<year>2003</year>). <article-title>Regulation of the human GLUT4 gene promoter: interaction between a transcriptional activator and myocyte enhancer factor 2A.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>100</volume>
<fpage>14725</fpage>–<lpage>14730</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.2432756100</pub-id>
<pub-id pub-id-type="pmid">14630949</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konopacki</surname><given-names>C.</given-names></name><name><surname>Pritykin</surname><given-names>Y.</given-names></name><name><surname>Rubtsov</surname><given-names>Y.</given-names></name><name><surname>Leslie</surname><given-names>C. S.</given-names></name><name><surname>Rudensky</surname><given-names>A. Y.</given-names></name></person-group> (<year>2019</year>). <article-title>Transcription factor Foxp1 regulates Foxp3 chromatin binding and coordinates regulatory T cell function.</article-title>
<source/><italic>Nat. Immunol.</italic>
<volume>20</volume>
<fpage>232</fpage>–<lpage>242</lpage>. <pub-id pub-id-type="doi">10.1038/s41590-018-0291-z</pub-id>
<pub-id pub-id-type="pmid">30643266</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lambert</surname><given-names>C.</given-names></name><name><surname>Cisternas</surname><given-names>P.</given-names></name><name><surname>Inestrosa</surname><given-names>N. C.</given-names></name></person-group> (<year>2016</year>). <article-title>Role of wnt signaling in central nervous system injury.</article-title>
<source/><italic>Mol. Neurobiol.</italic>
<volume>53</volume>
<fpage>2297</fpage>–<lpage>2311</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-015-9138-x</pub-id>
<pub-id pub-id-type="pmid">25976365</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Xiao</surname><given-names>J.</given-names></name><name><surname>Frohlich</surname><given-names>H.</given-names></name><name><surname>Tu</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Xu</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Foxp1 regulates cortical radial migration and neuronal morphogenesis in developing cerebral cortex.</article-title>
<source/><italic>PLoS One</italic>
<volume>10</volume>:<issue>e0127671</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0127671</pub-id>
<pub-id pub-id-type="pmid">26010426</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>G.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Jin</surname><given-names>S.</given-names></name><name><surname>Jiang</surname><given-names>Q.</given-names></name></person-group> (<year>2017a</year>). <article-title>Genetic variant rs763361 regulates multiple sclerosis CD226 gene expression.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>114</volume>
<fpage>E906</fpage>–<lpage>E907</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1618520114</pub-id>
<pub-id pub-id-type="pmid">28137889</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>G.</given-names></name><name><surname>Zhang</surname><given-names>F.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Jiang</surname><given-names>Y.</given-names></name><name><surname>Gong</surname><given-names>Z.</given-names></name><name><surname>Liu</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2017b</year>). <article-title>Multiple sclerosis risk pathways differ in Caucasian and Chinese populations.</article-title>
<source/><italic>J. Neuroimmunol.</italic>
<volume>307</volume>
<fpage>63</fpage>–<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1016/j.jneuroim.2017.03.012</pub-id>
<pub-id pub-id-type="pmid">28495140</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>G.</given-names></name><name><surname>Zhang</surname><given-names>F.</given-names></name><name><surname>Jiang</surname><given-names>Y.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Gong</surname><given-names>Z.</given-names></name><name><surname>Liu</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2017c</year>). <article-title>Integrating genome-wide association studies and gene expression data highlights dysregulated multiple sclerosis risk pathways.</article-title>
<source/><italic>Mult. Scler.</italic>
<volume>23</volume>
<fpage>205</fpage>–<lpage>212</lpage>. <pub-id pub-id-type="doi">10.1177/1352458516649038</pub-id>
<pub-id pub-id-type="pmid">27207450</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Llibre</surname><given-names>A.</given-names></name><name><surname>Lopez-Macias</surname><given-names>C.</given-names></name><name><surname>Marafioti</surname><given-names>T.</given-names></name><name><surname>Mehta</surname><given-names>H.</given-names></name><name><surname>Partridge</surname><given-names>A.</given-names></name><name><surname>Kanzig</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>LLT1 and CD161 expression in human germinal centers promotes B cell activation and CXCR4 downregulation.</article-title>
<source/><italic>J. Immunol.</italic>
<volume>196</volume>
<fpage>2085</fpage>–<lpage>2094</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1502462</pub-id>
<pub-id pub-id-type="pmid">26829983</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>X.</given-names></name><name><surname>Meng</surname><given-names>Z.</given-names></name><name><surname>Jin</surname><given-names>L.</given-names></name><name><surname>Xiao</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Tsark</surname><given-names>W. M.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>CAMK2gamma in intestinal epithelial cells modulates colitis-associated colorectal carcinogenesis via enhancing STAT3 activation.</article-title>
<source/><italic>Oncogene</italic>
<volume>36</volume>
<fpage>4060</fpage>–<lpage>4071</lpage>. <pub-id pub-id-type="doi">10.1038/onc.2017.16</pub-id>
<pub-id pub-id-type="pmid">28319059</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malik</surname><given-names>R.</given-names></name><name><surname>Chauhan</surname><given-names>G.</given-names></name><name><surname>Traylor</surname><given-names>M.</given-names></name><name><surname>Sargurupremraj</surname><given-names>M.</given-names></name><name><surname>Okada</surname><given-names>Y.</given-names></name><name><surname>Mishra</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>50</volume>
<fpage>524</fpage>–<lpage>537</lpage>.<pub-id pub-id-type="pmid">29531354</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malik</surname><given-names>R.</given-names></name><name><surname>Traylor</surname><given-names>M.</given-names></name><name><surname>Pulit</surname><given-names>S. L.</given-names></name><name><surname>Bevan</surname><given-names>S.</given-names></name><name><surname>Hopewell</surname><given-names>J. C.</given-names></name><name><surname>Holliday</surname><given-names>E. G.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Low-frequency and common genetic variation in ischemic stroke: the METASTROKE collaboration.</article-title>
<source/><italic>Neurology</italic>
<volume>86</volume>
<fpage>1217</fpage>–<lpage>1226</lpage>. <pub-id pub-id-type="doi">10.1212/wnl.0000000000002528</pub-id>
<pub-id pub-id-type="pmid">26935894</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marrie</surname><given-names>R. A.</given-names></name><name><surname>Reider</surname><given-names>N.</given-names></name><name><surname>Cohen</surname><given-names>J.</given-names></name><name><surname>Stuve</surname><given-names>O.</given-names></name><name><surname>Trojano</surname><given-names>M.</given-names></name><name><surname>Cutter</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis.</article-title>
<source/><italic>Mult. Scler.</italic>
<volume>21</volume>
<fpage>318</fpage>–<lpage>331</lpage>. <pub-id pub-id-type="doi">10.1177/1352458514564485</pub-id>
<pub-id pub-id-type="pmid">25533300</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McDonald</surname><given-names>W. I.</given-names></name><name><surname>Compston</surname><given-names>A.</given-names></name><name><surname>Edan</surname><given-names>G.</given-names></name><name><surname>Goodkin</surname><given-names>D.</given-names></name><name><surname>Hartung</surname><given-names>H. P.</given-names></name><name><surname>Lublin</surname><given-names>F. D.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.</article-title>
<source/><italic>Ann. Neurol.</italic>
<volume>50</volume>
<fpage>121</fpage>–<lpage>127</lpage>. <pub-id pub-id-type="doi">10.1002/ana.1032</pub-id>
<pub-id pub-id-type="pmid">11456302</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>Z.</given-names></name><name><surname>Ma</surname><given-names>X.</given-names></name><name><surname>Du</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>He</surname><given-names>M.</given-names></name><name><surname>Gu</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>CAMK2gamma antagonizes mTORC1 activation during hepatocarcinogenesis.</article-title>
<source/><italic>Oncogene</italic>
<volume>36</volume>
<fpage>2446</fpage>–<lpage>2456</lpage>. <pub-id pub-id-type="doi">10.1038/onc.2016.400</pub-id>
<pub-id pub-id-type="pmid">27819676</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mhatre</surname><given-names>S. D.</given-names></name><name><surname>Tsai</surname><given-names>C. A.</given-names></name><name><surname>Rubin</surname><given-names>A. J.</given-names></name><name><surname>James</surname><given-names>M. L.</given-names></name><name><surname>Andreasson</surname><given-names>K. I.</given-names></name></person-group> (<year>2015</year>). <article-title>Microglial malfunction: the third rail in the development of Alzheimer’s disease.</article-title>
<source/><italic>Trends Neurosci.</italic>
<volume>38</volume>
<fpage>621</fpage>–<lpage>636</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2015.08.006</pub-id>
<pub-id pub-id-type="pmid">26442696</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>A.</given-names></name><name><surname>Macgregor</surname><given-names>S.</given-names></name></person-group> (<year>2015</year>). <article-title>VEGAS2: software for more flexible gene-based testing.</article-title>
<source/><italic>Twin Res. Hum. Genet.</italic>
<volume>18</volume>
<fpage>86</fpage>–<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1017/thg.2014.79</pub-id>
<pub-id pub-id-type="pmid">25518859</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moutsianas</surname><given-names>L.</given-names></name><name><surname>Jostins</surname><given-names>L.</given-names></name><name><surname>Beecham</surname><given-names>A. H.</given-names></name><name><surname>Dilthey</surname><given-names>A. T.</given-names></name><name><surname>Xifara</surname><given-names>D. K.</given-names></name><name><surname>Ban</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Class II HLA interactions modulate genetic risk for multiple sclerosis.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>47</volume>
<fpage>1107</fpage>–<lpage>1113</lpage>. <pub-id pub-id-type="doi">10.1038/ng.3395</pub-id>
<pub-id pub-id-type="pmid">26343388</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Connell</surname><given-names>G. C.</given-names></name><name><surname>Treadway</surname><given-names>M. B.</given-names></name><name><surname>Petrone</surname><given-names>A. B.</given-names></name><name><surname>Tennant</surname><given-names>C. S.</given-names></name><name><surname>Lucke-Wold</surname><given-names>N.</given-names></name><name><surname>Chantler</surname><given-names>P. D.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Peripheral blood AKAP7 expression as an early marker for lymphocyte-mediated post-stroke blood brain barrier disruption.</article-title>
<source/><italic>Sci. Rep.</italic>
<volume>7</volume>:<issue>1172</issue>.</mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Roak</surname><given-names>B. J.</given-names></name><name><surname>Deriziotis</surname><given-names>P.</given-names></name><name><surname>Lee</surname><given-names>C.</given-names></name><name><surname>Vives</surname><given-names>L.</given-names></name><name><surname>Schwartz</surname><given-names>J. J.</given-names></name><name><surname>Girirajan</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>43</volume>
<fpage>585</fpage>–<lpage>589</lpage>. <pub-id pub-id-type="doi">10.1038/ng.835</pub-id>
<pub-id pub-id-type="pmid">21572417</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oshel</surname><given-names>K. M.</given-names></name><name><surname>Knight</surname><given-names>J. B.</given-names></name><name><surname>Cao</surname><given-names>K. T.</given-names></name><name><surname>Thai</surname><given-names>M. V.</given-names></name><name><surname>Olson</surname><given-names>A. L.</given-names></name></person-group> (<year>2000</year>). <article-title>Identification of a 30-base pair regulatory element and novel DNA binding protein that regulates the human GLUT4 promoter in transgenic mice.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>275</volume>
<fpage>23666</fpage>–<lpage>23673</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M001452200</pub-id>
<pub-id pub-id-type="pmid">10825161</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rieger</surname><given-names>M. E.</given-names></name><name><surname>Sims</surname><given-names>A. H.</given-names></name><name><surname>Coats</surname><given-names>E. R.</given-names></name><name><surname>Clarke</surname><given-names>R. B.</given-names></name><name><surname>Briegel</surname><given-names>K. J.</given-names></name></person-group> (<year>2010</year>). <article-title>The embryonic transcription cofactor LBH is a direct target of the Wnt signaling pathway in epithelial development and in aggressive basal subtype breast cancers.</article-title>
<source/><italic>Mol. Cell Biol.</italic>
<volume>30</volume>
<fpage>4267</fpage>–<lpage>4279</lpage>. <pub-id pub-id-type="doi">10.1128/mcb.01418-09</pub-id>
<pub-id pub-id-type="pmid">20606007</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rokita</surname><given-names>A. G.</given-names></name><name><surname>Anderson</surname><given-names>M. E.</given-names></name></person-group> (<year>2012</year>). <article-title>New therapeutic targets in cardiology: arrhythmias and Ca2+/calmodulin-dependent kinase II (CaMKII).</article-title>
<source/><italic>Circulation</italic>
<volume>126</volume>
<fpage>2125</fpage>–<lpage>2139</lpage>. <pub-id pub-id-type="doi">10.1161/circulationaha.112.124990</pub-id>
<pub-id pub-id-type="pmid">23091085</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosen</surname><given-names>D. B.</given-names></name><name><surname>Bettadapura</surname><given-names>J.</given-names></name><name><surname>Alsharifi</surname><given-names>M.</given-names></name><name><surname>Mathew</surname><given-names>P. A.</given-names></name><name><surname>Warren</surname><given-names>H. S.</given-names></name><name><surname>Lanier</surname><given-names>L. L.</given-names></name></person-group> (<year>2005</year>). <article-title>Cutting edge: lectin-like transcript-1 is a ligand for the inhibitory human NKR-P1A receptor.</article-title>
<source/><italic>J. Immunol.</italic>
<volume>175</volume>
<fpage>7796</fpage>–<lpage>7799</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.175.12.7796</pub-id>
<pub-id pub-id-type="pmid">16339513</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosen</surname><given-names>D. B.</given-names></name><name><surname>Cao</surname><given-names>W.</given-names></name><name><surname>Avery</surname><given-names>D. T.</given-names></name><name><surname>Tangye</surname><given-names>S. G.</given-names></name><name><surname>Liu</surname><given-names>Y. J.</given-names></name><name><surname>Houchins</surname><given-names>J. P.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Functional consequences of interactions between human NKR-P1A and its ligand LLT1 expressed on activated dendritic cells and B cells.</article-title>
<source/><italic>J. Immunol.</italic>
<volume>180</volume>
<fpage>6508</fpage>–<lpage>6517</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.180.10.6508</pub-id>
<pub-id pub-id-type="pmid">18453569</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sagardoy</surname><given-names>A.</given-names></name><name><surname>Martinez-Ferrandis</surname><given-names>J. I.</given-names></name><name><surname>Roa</surname><given-names>S.</given-names></name><name><surname>Bunting</surname><given-names>K. L.</given-names></name><name><surname>Aznar</surname><given-names>M. A.</given-names></name><name><surname>Elemento</surname><given-names>O.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Downregulation of FOXP1 is required during germinal center B-cell function.</article-title>
<source/><italic>Blood</italic>
<volume>121</volume>
<fpage>4311</fpage>–<lpage>4320</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2012-10-462846</pub-id>
<pub-id pub-id-type="pmid">23580662</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>C.</given-names></name><name><surname>Sakuma</surname><given-names>M.</given-names></name><name><surname>Mooroka</surname><given-names>T.</given-names></name><name><surname>Liscoe</surname><given-names>A.</given-names></name><name><surname>Gao</surname><given-names>H.</given-names></name><name><surname>Croce</surname><given-names>K. J.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Down-regulation of the forkhead transcription factor Foxp1 is required for monocyte differentiation and macrophage function.</article-title>
<source/><italic>Blood</italic>
<volume>112</volume>
<fpage>4699</fpage>–<lpage>4711</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2008-01-137018</pub-id>
<pub-id pub-id-type="pmid">18799727</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stamova</surname><given-names>B.</given-names></name><name><surname>Jickling</surname><given-names>G. C.</given-names></name><name><surname>Ander</surname><given-names>B. P.</given-names></name><name><surname>Zhan</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>D.</given-names></name><name><surname>Turner</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Gene expression in peripheral immune cells following cardioembolic stroke is sexually dimorphic.</article-title>
<source/><italic>PLoS One</italic>
<volume>9</volume>:<issue>e102550</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0102550</pub-id>
<pub-id pub-id-type="pmid">25036109</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stephen</surname><given-names>T. L.</given-names></name><name><surname>Rutkowski</surname><given-names>M. R.</given-names></name><name><surname>Allegrezza</surname><given-names>M. J.</given-names></name><name><surname>Perales-Puchalt</surname><given-names>A.</given-names></name><name><surname>Tesone</surname><given-names>A. J.</given-names></name><name><surname>Svoronos</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Transforming growth factor beta-mediated suppression of antitumor T cells requires FoxP1 transcription factor expression.</article-title>
<source/><italic>Immunity</italic>
<volume>41</volume>
<fpage>427</fpage>–<lpage>439</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2014.08.012</pub-id>
<pub-id pub-id-type="pmid">25238097</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>K.</given-names></name><name><surname>Shouguchi-Miyata</surname><given-names>J.</given-names></name><name><surname>Miyamoto</surname><given-names>N.</given-names></name><name><surname>Ikeda</surname><given-names>J. E.</given-names></name></person-group> (<year>2004</year>). <article-title>Novel nuclear shuttle proteins, HDBP1 and HDBP2, bind to neuronal cell-specific cis-regulatory element in the promoter for the human Huntington’s disease gene.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>279</volume>
<fpage>7275</fpage>–<lpage>7286</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M310726200</pub-id>
<pub-id pub-id-type="pmid">14625278</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>B.</given-names></name><name><surname>Becanovic</surname><given-names>K.</given-names></name><name><surname>Desplats</surname><given-names>P. A.</given-names></name><name><surname>Spencer</surname><given-names>B.</given-names></name><name><surname>Hill</surname><given-names>A. M.</given-names></name><name><surname>Connolly</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Forkhead box protein p1 is a transcriptional repressor of immune signaling in the CNS: implications for transcriptional dysregulation in Huntington disease.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>21</volume>
<fpage>3097</fpage>–<lpage>3111</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/dds132</pub-id>
<pub-id pub-id-type="pmid">22492998</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>D. C.</given-names></name><name><surname>Shi</surname><given-names>K.</given-names></name><name><surname>Zhu</surname><given-names>Z.</given-names></name><name><surname>Yao</surname><given-names>J.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Su</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Fingolimod enhances the efficacy of delayed alteplase administration in acute ischemic stroke by promoting anterograde reperfusion and retrograde collateral flow.</article-title>
<source/><italic>Ann. Neurol.</italic>
<volume>84</volume>
<fpage>717</fpage>–<lpage>728</lpage>. <pub-id pub-id-type="doi">10.1002/ana.25352</pub-id>
<pub-id pub-id-type="pmid">30295338</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>Y.</given-names></name><name><surname>Stamova</surname><given-names>B.</given-names></name><name><surname>Jickling</surname><given-names>G. C.</given-names></name><name><surname>Liu</surname><given-names>D.</given-names></name><name><surname>Ander</surname><given-names>B. P.</given-names></name><name><surname>Bushnell</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Effects of gender on gene expression in the blood of ischemic stroke patients.</article-title>
<source/><italic>J. Cereb. Blood Flow Metab.</italic>
<volume>32</volume>
<fpage>780</fpage>–<lpage>791</lpage>. <pub-id pub-id-type="doi">10.1038/jcbfm.2011.179</pub-id>
<pub-id pub-id-type="pmid">22167233</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torres-Aguila</surname><given-names>N. P.</given-names></name><name><surname>Carrera</surname><given-names>C.</given-names></name><name><surname>Giese</surname><given-names>A. K.</given-names></name><name><surname>Cullell</surname><given-names>N.</given-names></name><name><surname>Muiño</surname><given-names>E.</given-names></name><name><surname>Cárcel-Márquez</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Genome-wide association study of white blood cell counts in patients with ischemic stroke.</article-title>
<source/><italic>Stroke</italic>
<volume>50</volume>
<fpage>3618</fpage>–<lpage>3621</lpage>. <pub-id pub-id-type="doi">10.1161/strokeaha.119.026593</pub-id>
<pub-id pub-id-type="pmid">31587654</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Traylor</surname><given-names>M.</given-names></name><name><surname>Farrall</surname><given-names>M.</given-names></name><name><surname>Holliday</surname><given-names>E. G.</given-names></name><name><surname>Sudlow</surname><given-names>C.</given-names></name><name><surname>Hopewell</surname><given-names>J. C.</given-names></name><name><surname>Cheng</surname><given-names>Y. C.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies.</article-title>
<source/><italic>Lancet Neurol.</italic>
<volume>11</volume>
<fpage>951</fpage>–<lpage>962</lpage>. <pub-id pub-id-type="doi">10.1016/s1474-4422(12)70234-x</pub-id><pub-id pub-id-type="pmid">23041239</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tseng</surname><given-names>C. H.</given-names></name><name><surname>Huang</surname><given-names>W. S.</given-names></name><name><surname>Lin</surname><given-names>C. L.</given-names></name><name><surname>Chang</surname><given-names>Y. J.</given-names></name></person-group> (<year>2015</year>). <article-title>Increased risk of ischaemic stroke among patients with multiple sclerosis.</article-title>
<source/><italic>Eur. J. Neurol.</italic>
<volume>22</volume>
<fpage>500</fpage>–<lpage>506</lpage>. <pub-id pub-id-type="doi">10.1111/ene.12598</pub-id>
<pub-id pub-id-type="pmid">25443663</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Geng</surname><given-names>J.</given-names></name><name><surname>Wen</surname><given-names>X.</given-names></name><name><surname>Bi</surname><given-names>E.</given-names></name><name><surname>Kossenkov</surname><given-names>A. V.</given-names></name><name><surname>Wolf</surname><given-names>A. I.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>The transcription factor Foxp1 is a critical negative regulator of the differentiation of follicular helper T cells.</article-title>
<source/><italic>Nat. Immunol.</italic>
<volume>15</volume>
<fpage>667</fpage>–<lpage>675</lpage>. <pub-id pub-id-type="doi">10.1038/ni.2890</pub-id>
<pub-id pub-id-type="pmid">24859450</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wechsler</surname><given-names>L. R.</given-names></name><name><surname>Bates</surname><given-names>D.</given-names></name><name><surname>Stroemer</surname><given-names>P.</given-names></name><name><surname>Andrews-Zwilling</surname><given-names>Y. S.</given-names></name><name><surname>Aizman</surname><given-names>I.</given-names></name></person-group> (<year>2018</year>). <article-title>Cell therapy for chronic stroke.</article-title>
<source/><italic>Stroke</italic>
<volume>49</volume>
<fpage>1066</fpage>–<lpage>1074</lpage>. <pub-id pub-id-type="doi">10.1161/strokeaha.117.018290</pub-id>
<pub-id pub-id-type="pmid">29669865</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wijchers</surname><given-names>P. J.</given-names></name><name><surname>Burbach</surname><given-names>J. P.</given-names></name><name><surname>Smidt</surname><given-names>M. P.</given-names></name></person-group> (<year>2006</year>). <article-title>In control of biology: of mice, men and Foxes.</article-title>
<source/><italic>Biochem. J.</italic>
<volume>397</volume>
<fpage>233</fpage>–<lpage>246</lpage>. <pub-id pub-id-type="doi">10.1042/bj20060387</pub-id>
<pub-id pub-id-type="pmid">16792526</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamaguchi-Kabata</surname><given-names>Y.</given-names></name><name><surname>Morihara</surname><given-names>T.</given-names></name><name><surname>Ohara</surname><given-names>T.</given-names></name><name><surname>Ninomiya</surname><given-names>T.</given-names></name><name><surname>Takahashi</surname><given-names>A.</given-names></name><name><surname>Akatsu</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Integrated analysis of human genetic association study and mouse transcriptome suggests LBH and SHF genes as novel susceptible genes for amyloid-beta accumulation in Alzheimer’s disease.</article-title>
<source/><italic>Hum. Genet.</italic>
<volume>137</volume>
<fpage>521</fpage>–<lpage>533</lpage>.<pub-id pub-id-type="pmid">30006735</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>J.</given-names></name><name><surname>Das</surname><given-names>S.</given-names></name><name><surname>Roy</surname><given-names>A.</given-names></name><name><surname>Wei</surname><given-names>W.</given-names></name><name><surname>Huang</surname><given-names>H.</given-names></name><name><surname>Lorenz-Guertin</surname><given-names>J. M.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Ischemic injury-induced CaMKIIdelta and CaMKIIgamma confer neuroprotection through the NF-kappaB signaling pathway.</article-title>
<source/><italic>Mol. Neurobiol.</italic>
<volume>56</volume>
<fpage>2123</fpage>–<lpage>2136</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-018-1198-2</pub-id>
<pub-id pub-id-type="pmid">29992531</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yokoyama</surname><given-names>W. M.</given-names></name><name><surname>Plougastel</surname><given-names>B. F.</given-names></name></person-group> (<year>2003</year>). <article-title>Immune functions encoded by the natural killer gene complex.</article-title>
<source/><italic>Nat. Rev. Immunol.</italic>
<volume>3</volume>
<fpage>304</fpage>–<lpage>316</lpage>. <pub-id pub-id-type="doi">10.1038/nri1055</pub-id>
<pub-id pub-id-type="pmid">12669021</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>G. L.</given-names></name><name><surname>Wei</surname><given-names>E. Q.</given-names></name><name><surname>Zhang</surname><given-names>S. H.</given-names></name><name><surname>Xu</surname><given-names>H. M.</given-names></name><name><surname>Chu</surname><given-names>L. S.</given-names></name><name><surname>Zhang</surname><given-names>W. P.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice.</article-title>
<source/><italic>Pharmacology</italic>
<volume>73</volume>
<fpage>31</fpage>–<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1159/000081072</pub-id>
<pub-id pub-id-type="pmid">15452361</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>Z. Y.</given-names></name><name><surname>Lu</surname><given-names>W. S.</given-names></name><name><surname>Zuo</surname><given-names>X. B.</given-names></name><name><surname>Hu</surname><given-names>J.</given-names></name><name><surname>Yao</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>One novel susceptibility locus associate with systemic lupus erythematosus in Chinese Han population.</article-title>
<source/><italic>Rheumatol. Int.</italic>
<volume>33</volume>
<fpage>2079</fpage>–<lpage>2083</lpage>. <pub-id pub-id-type="doi">10.1007/s00296-013-2697-0</pub-id>
<pub-id pub-id-type="pmid">23408151</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhernakova</surname><given-names>A.</given-names></name><name><surname>Stahl</surname><given-names>E. A.</given-names></name><name><surname>Trynka</surname><given-names>G.</given-names></name><name><surname>Raychaudhuri</surname><given-names>S.</given-names></name><name><surname>Festen</surname><given-names>E. A.</given-names></name><name><surname>Franke</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci.</article-title>
<source/><italic>PLoS Genet.</italic>
<volume>7</volume>:<issue>e1002004</issue>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1002004</pub-id>
<pub-id pub-id-type="pmid">21383967</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Z.</given-names></name><name><surname>Fu</surname><given-names>Y.</given-names></name><name><surname>Tian</surname><given-names>D.</given-names></name><name><surname>Sun</surname><given-names>N.</given-names></name><name><surname>Han</surname><given-names>W.</given-names></name><name><surname>Chang</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Combination of the immune modulator fingolimod with alteplase in acute ischemic stroke: a pilot trial.</article-title>
<source/><italic>Circulation</italic>
<volume>132</volume>
<fpage>1104</fpage>–<lpage>1112</lpage>. <pub-id pub-id-type="doi">10.1161/circulationaha.115.016371</pub-id>
<pub-id pub-id-type="pmid">26202811</pub-id></mixed-citation>
</ref>
</ref-list>
<glossary>
<title>Abbreviations</title>
<def-list id="DL1">
<def-item>
<term>CNS</term>
<def>
<p>central nervous system</p>
</def>
</def-item>
<def-item>
<term>GEO</term>
<def>
<p>gene expression omnibus</p>
</def>
</def-item>
<def-item>
<term>GWASs</term>
<def>
<p>large-scale genome-wide association studies</p>
</def>
</def-item>
<def-item>
<term>IMSGC</term>
<def>
<p>International MS Genetics Consortium</p>
</def>
</def-item>
<def-item>
<term>IS</term>
<def>
<p>ischemic stroke</p>
</def>
</def-item>
<def-item>
<term>LD</term>
<def>
<p>linkage disequilibrium</p>
</def>
</def-item>
<def-item>
<term>MS</term>
<def>
<p>multiple sclerosis</p>
</def>
</def-item>
<def-item>
<term>PBMCs</term>
<def>
<p>peripheral blood mononuclear cells</p>
</def>
</def-item>
<def-item>
<term>QC</term>
<def>
<p>quality control</p>
</def>
</def-item>
<def-item>
<term>RA</term>
<def>
<p>rheumatoid arthritis</p>
</def>
</def-item>
<def-item>
<term>SLE</term>
<def>
<p>systemic lupus erythematosus</p>
</def>
</def-item>
<def-item>
<term>SNP</term>
<def>
<p>single nucleotide polymorphism</p>
</def>
</def-item>
<def-item>
<term>TF</term>
<def>
<p>transcription factor</p>
</def>
</def-item>
<def-item>
<term>VEGAS2</term>
<def>
<p>Versatile Gene-based Association Study-2 version 2</p>
</def>
</def-item>
<def-item>
<term>VRFCs</term>
<def>
<p>vascular risk factor controls</p>
</def>
</def-item>
<def-item>
<term>WTCCC2</term>
<def>
<p>Wellcome Trust Case Control Consortium 2.</p>
</def>
</def-item>
</def-list>
</glossary>
</back>
</article>
</pmc-articleset>